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INTRODUCTION 
 Decades of silent arterial wall alterations precede vascular clinical 
events, which then reflect advanced atherosclerotic disease. The first 
morphological abnormalities of arterial walls can be visualized by B-
mode ultrasonography. This high-resolution, noninvasive technique is 
one of the best methods for the detection of early stages of atherosclerotic 
disease, because it is rapidly applicable, readily available and 
demonstrates the wall structure with better resolution than any other 
similar technique .Accordingly, ultrasound has been used in a number of 
studies to monitor the intima-media thickness (IMT) of the carotid 
arteries, a measurement which has consequently been shown to be 
associated with cardiovascular risk factors and the incidence of 
cardiovascular disease. Furthermore, there are diverse approaches for 
measuring IMT, and some of these may lead to divergent results. 
Moreover, there are no unified criteria for distinguishing atherosclerosis 
as seen in early plaque formation from thickening of the intimal-medial 
complex. This is because IMT reflects not only early atherosclerosis, but 
also non atherosclerotic compensatory enlargement with largely medial 
hypertrophy as a result of smooth muscle cell hyperplasia and fibro 
cellular hypertrophy. This differentiation is important because 
epidemiological studies have shown that wall thickening as depicted by 
ultrasonographic measurements of IMT is different from atherosclerotic 
plaque regarding localization, natural history, risk factors and predictive 
value for vascular events. As IMT is being increasingly used in clinical 
trials to serve as a surrogate end point for determining the success of 
interventions that lower risk factors for atherosclerosis, it is imperative 
that standardized methods be used to allow homogenous data collection 
and analysis. This would help to improve the power of such studies and to 
facilitate the merging of large databases for meta-analyses. In our study 
correlation of intima medial thickness with carotid artery remodeling and 
coronary artery disease status is assessed   
 
 
 
 
 
 
 
 
 
                                      
                                   
 
 
AIM OF THE STUDY 
AIM OF STUDY 
          To study the carotid arterial remodeling in patients with coronary 
artery disease 
 To study   the relationship between carotid arterial inter adventitial 
and lumen diameters to the intima medial thickness  
 To evaluate carotid arterial diameters of individuals with coronary 
artery disease  and how it differed from those of CAD-free controls and  
          To study the relationship between  carotid artery remodeling and 
severity of cornary artery disease  
 
 
 
 
 
 
REVIEW OF LITERATURE 
Many clinical studies support the opinion that carotid intima-media 
thickness (IMT) assessed by B-mode ultrasound in carotid arteries, either 
in a single segment (common carotid) or in multiple segments (aggregate 
of measures in common carotids, bifurcations, and internal carotids), is a 
valuable mirror of coronary risk status and a worthwhile predictor of 
subsequent coronary heart disease (CHD), the leading source of 
cardiovascular death. Indeed, traditional and emerging risk factors for 
CHD have been found mostly to be closely correlated with increased 
carotid IMT. Also, increased carotid IMT is associated with substantially 
increased risk of a future CHD event in primary and secondary prevention 
populations. Thus, by analyzing the proportion of subjects developing a 
CHD event according to the carotid IMT level at the onset of the follow-
up in two pioneering prospective population-based studies, it has been 
shown that markedly increased IMT above 1 mm was associated with a 
12–16% 10-year CHD incidence depending on age, sex, and carotid 
segment(s) measured, whereas the lowest percentiles of IMT distribution 
were associated with a CHD incidence of consistently <0.5%. 
 Carotid intima-media thickness (IMT) is a marker for early 
atherosclerosis. Because it can be measured relatively simply and non 
invasively, it is well suited for use in large-scale population studies. 
Ultrasonic measurements correlate well with histology, and increased 
IMT is associated with vascular risk factors and the presence of more 
advanced atherosclerosis, which includes coronary artery disease. IMT is 
being increasingly used for risk stratification in individuals and as an end 
point in intervention studies. An important precondition for this 
application of IMT is that it can predict future risk of clinical vascular 
events. A number of longitudinal studies have examined the relationship 
between IMT and future events, most frequently the incidence of cardiac 
events (myocardial infarction [MI], angina pectoris, and coronary 
intervention) and cerebrovascular events (stroke or transient ischemic 
attack [TIA]). 
 Carotid intima-media thickness (IMT) measurements are being 
applied widely as a measure of atherosclerosis in studies on determinants 
of presence and progression of atherosclerosis and in studies on 
atherosclerosis as determinant of cardiovascular disease. Carotid IMT has 
been shown to be related to cardiovascular risk factors, prevalent 
cardiovascular disease, and atherosclerosis in the peripheral, coronary, 
and femoral arteries. Recently, evidence became available indicating that 
an increased carotid IMT is a strong predictor of coronary heart disease 
and stroke 
 Carotid intima-media thickness (CIMT) is a non-invasive 
alternative marker of atherosclerotic disease that has been used 
extensively since 1987. CIMT is defined as the distance between the 
lumen-intima interface, which corresponds to the inner and outer 
echogenic lines seen on the B-mode ultrasound image. Increased CIMT 
has consistently been shown to predict future vascular events. In addition, 
change in CIMT over time is currently used in randomized controlled 
trials (RCTs) as an alternative (surrogate) end point for cardiovascular 
events to evaluate the efficacy of interventions because of its advantage 
of considerable reductions in sample size and duration of follow-up in 
comparison to traditional morbidity-mortality event trials.   
ARTERIAL REMODELING 
 The process of arterial remodeling, i.e., the change in structural 
arterial properties through time in response to atherogenic and/or 
hemodynamic alterations within the arterial environment, is thought to be 
an adaptive phenomenon aimed at maintaining circumferential wall and 
shear stresses within certain limits of operation and possibly at preserving 
compliance. Arterial remodeling is characterized by wall thickening 
(indicated by an increase in intima-media thickness (IMT)] and diameter 
widening [indicated by an increase in interadventitial diameter [IAD]).At 
the biochemical level, arterial remodeling is characterized by a complex 
set of interactions between vasoactive molecules (eg, nitric oxide), 
enzymes (eg, matrix metalloproteinase), and inflammatory cells 
(monocytes/macrophages). 
 Three different patterns of arterial remodeling have been identified: 
inward (characterized by a decrease in lumen diameter [LD] resulting 
from a greater change in IMT than in IAD), outward (characterized by an 
increase in LD caused by a greater change in IAD than in IMT), and 
compensatory (characterized by LD preservation despite changes in IMT 
and IAD) remodeling. Recent studies suggested that inward remodeling 
and outward remodeling are associated with distinct forms of plaque 
formation, ie, inward with stable plaque formation and outward with 
unstable plaque formation. As such, inward remodeling and outward 
remodeling have been recognized as markers of CVD risk. Yet, it is 
unclear to what extent the process of remodeling is driven by atherogenic 
factors (i.e., the presence of atherosclerosis) compared with hemodynamic 
factors (i.e., increased blood pressure). This is of particular importance 
because increased IMT could be the consequence of an unfavourable 
atherogenic milieu, subsequently leading to increases in IAD (i.e., the 
increase in IMT drives the increase in IAD), whereas alternatively IAD 
could be the consequence of an unfavorable hemodynamic milieu, which 
in turn could lead to increases in IMT (i.e., the increase in IAD drives the 
increase in IMT). Alternatively, changes in IMT and IAD may be driven 
by different processes and thus be unrelated 
Mannheim Carotid Intima-Media Thickness Consensus 32 
IMT and Early Plaque 
In the absence of atherosclerotic plaque, B-mode ultrasound displays the 
vascular wall as a regular pattern that correlates with anatomical layers. 
The intima-media portion of this pattern is represented by the area of 
tissue starting at the luminal edge of the artery and ending at the 
boundary between the media and the adventitia. This interface is well 
depicted by ultrasound. With increasing age, this pattern has been shown 
to thicken in a uniform way in straight arterial segments. Thickening of 
the intima-media is accelerated and enhanced in the presence of risk 
factors of atherosclerosis, particularly high blood pressure, and by 
inherited genetic factors. As a mirror of these processes, IMT was 
identified as a tool to investigate normal aging and preclinical 
atherosclerosis. Later stages of atherosclerosis (plaque, stenosis, 
occlusion) can also be identified by ultrasound imaging either in the 
absence of or coincident with increasing IMT. However, there are 
intermediate stages between increased IMT and atherosclerotic plaque 
formation that cannot clearly be differentiated either by ultrasound or by 
histological examination. Such conditions are common at the bifurcation 
and the origin of the internal carotid artery, but occur only occasionally in 
the common carotid artery (CCA). Epidemiological and intervention 
studies have shown that although both share some common 
atherosclerosis risk factors, the natural history, patterns of risk factors and 
the prediction of cardiac and cerebral events are different for carotid IMT 
and carotid plaque.  
The consensus recommends the following definitions for ultrasound 
characterization of IMT and atherosclerotic plaque: 
(1) IMT is a double-line pattern visualized by echo tomography on both 
walls of the CCA s in a longitudinal image. It is formed by two parallel 
lines, which consist of the leading edges of two anatomical boundaries: 
the lumen-intima and media-adventitia interfaces (2) Plaque is a focal 
structure encroaching into the arterial lumen of at least 0.5 mm or 50% of 
the surrounding IMT value, or demonstrates a thickness >1.5 mm as 
measured from the media-adventitia interface to the intima-lumen 
interface.  
These definitions will allow classification of the vast majority of carotid 
lesions observed with ultrasound. 
Carotid examination includes visualization of common, internal and 
external carotid arteries. The different ultrasound devices are 
continuously evolving, providing higher spatial and density resolutions, 
and improving information on all the structures visualized is waiting for a 
scientific validation of the superiority of 3-dimensional over 2-
dimensional imaging. We propose some rules to improve 2-dimensional 
image acquisition based on ultrasound physics and basic anatomy. 
Ultrasound physics principles: 
- Ultrasound beam is a virtual biconcave lens which is thicker on the near 
and distal part of the field represented on the screen. For that reason, the 
best resolution is commonly obtained in the mid part of this field. 
Perpendicularity between the ultrasound beam and the structures to be 
visualized provides the best information as the reflection of the incident 
beam is optimal. The energy of the ultrasound beam decreases with the 
distance and is usually reduced in the far part of the field. Frequency of 
emission determines the resolution. The higher the frequency, the higher 
the resolution, however, frequency is inversely proportional to the depth 
to explore. Linear transducers activate piezo -electric crystals 
simultaneously resulting in a synchronized propagation of the ultrasound 
wave. Sector scanners are typically activating crystals sequentially in pre-
defined time intervals, causing asymmetric shifts and reception of skewed 
wave fronts. Linear ultrasound transducers therefore provide best image 
quality for superficial arteries, while electronic sector scanners are better 
used for deep structures with less accessibility. 
Physiological and patho physiological principles: 
 Common and internal carotid arteries are quite homogeneous in structure 
and hemodynamics. Delimited at the origin by the brachio-arterial 
cephalic trunk on the right side and the aortic arch on the left side, the 
CCA ends at the bifurcation which is represented anatomically by the 
point of divergence of the walls of the CCA .The bifurcation is rather 
heterogeneous between individuals. Since atherosclerosis usually starts in 
the carotid bulb, delineation of the different segments is required. The 
continuous related progression of vascular wall changes best monitored in 
CCA IMT studies is different from discontinuous focal lesions (plaque) 
which are characteristic of atherosclerotic disease. Therefore, distinction 
between IMT and plaque must be clearly specified in the scanning 
protocols.  
Methods of measuring the intima medial thickness  
The IMT can be assessed in nearly every patient. Successful examination 
of the internal carotid artery and of the carotid bulb depends both upon 
the anatomical topography of the patient and on sono grapher expertise. 
(1) Measurement of IMT is most simply performed in a region free of 
plaque where the double-line pattern is observed - this is advantageous as 
measurements are easier, more accurate, and reproducible and can be 
standardized by computerized analyses.  
(2) IMT can be measured in the CCA, at the bulb and the origin of the 
internal carotid artery.  
(3) In study designs that include wall thickness, values obtained from 
different sites of the carotid arteries should be documented separately. 
 Methods of analyzing the data 
CCA acquisition with ultrasound should be conducted as follows. 
Standard equipment includes a high-resolution B-mode system operating 
with preferentially linear ultrasound transducers at frequencies >7 MHz. 
Appropriate depth of focus (e.g. 30-40 mm), frame rate optimally 25 Hz 
(>15 Hz), and gain settings (minimal intra luminal artifacts) are 
recommended to obtain optimal image quality. Log gain compensation 
should be around 60 dB. They must be adjusted to obtain a symmetrical 
brightness on near and far wall, decreasing if necessary the gain in the 
mid part of the field to avoid intraluminal artifacts. 
Carotid IMT scanning and reading protocol recommendations: 
(1) The arterial wall segments should be assessed in a longitudinal view, 
strictly perpendicular to the ultrasound beam, with both walls clearly 
visualized in order to achieve diameter measurements. Lateral probe 
incidence is recommended as it offers the best view in the middle field, 
where the resolution is known to be greater than in the near or far field. A 
horizontal display of the arterial image is also recommended to obtain the 
optimal interfaces between blood and vascular structures, on the longest 
possible segment. The localization of the end of the CA is necessary to 
help in repositioning during the follow-up. 
(2) IMT should be measured preferably on the far wall. This is because 
IMT values from the near wall depend in part on gain settings and are less 
reliable. If taken on the near wall, IMT should be measured separately 
from IMT of the far wall.  
(3) Along a minimum of 10 mm length of an arterial segment, a high-
quality image acquisition is required for serial reproducible 
measurements. Due to vessel tortuosity, IMT measurement could only be 
possible at a shorter vessel segment, especially in the carotid bifurcation 
or the ICA bulb. 
(4) Edge detection systems that are properly calibrated provide accurate 
measurements of IMT. Observations made by readers may be equally 
valid, but they require rigorous quality control and quality assurance. In 
addition, manual and semi-manual reading methods are extremely time 
consuming in comparison to automated systems, which can provide the 
mean maximal value of 150 measurements performed on a 10-mm 
segment of CA in a very short time (<0.1 s).  
(5) Adventitia-to-adventitia diameter and intraluminal diameter of CA 
must also be measured as IMT is significantly correlated with the arterial 
diameter. 
(6) Another important issue is the question which IMT measure (e.g. 
mean IMT value, maximal IMT value, and composite measures from the 
left and the right side or from different arterial sites) should be used. 
There is no definite answer to this question. It seems to be plausible that 
mean IMT values as averaged across the entire distance are less 
susceptible to outliers, whereas the maximal IMT may reflect more 
advanced stages with focal thickening towards plaque formation. It is 
accepted that IMT values from the left and right side could be averaged 
although there is a significant difference between the left and right CA 
IMT, with higher values on the left side .Composite scores including both 
plaque and IMT measure should be avoided. In conclusion, data 
acquisition should be as detailed as possible, and data analysis can be 
restricted to single measures to reduce multiple testing problems. 
(7) Each vascular laboratory must perform periodical quality control of 
their equipment (phantom scans) and reliability studies of scans and 
measurements for ultra sonographers and readers. The intra class 
correlation coefficient should be evaluated for intra- and inter observer 
variability, both for IMT and plaque measurements. 
 Population to be investigated  
Standard and regular use of IMT measurements are recommended in all 
epidemiological and interventional trials dealing with vascular diseases to 
better characterize the population investigated (similarly to the 
documentation of other risk factors). Determination of 'normal values' 
should help to better characterize 'intermediate' risk populations in the 
future. The moderate but significant correlation between IMT and 
Framingham score observed in a large population (PARC Study) raises 
the question of the best indicator for vascular event in individuals. IMT 
measurement is the first candidate to evaluate against conventional 
evaluation of cardiovascular risk. In some countries recommendations 
already suggest that carefully performed IMT measurement can add 
incremental information to traditional risk factor assessment (European 
Society of Cardiology Guidelines).  
Ancillary studies in clinical trials should be sufficiently powered to 
contribute to evaluating the predictive value of IMT on reduction of 
clinical events. 
There is no recommendation up to date neither to ‘treat IMT values’ nor 
to monitor IMT values in individual patients.  
Recent studies have shown that reduction of IMT values is significantly 
correlated with risk reduction and improvement of risk factor profiles in 
large populations. However, neither positive nor negative predictive 
values on ischemic risk reduction are known in individual subjects treated 
successfully for specific risk factors. Thus, although IMT has been 
suggested to represent an important risk marker, it does not fulfill the 
characteristics of an accepted risk factor. At present, carotid IMT is not 
an FDA approved surrogate end point of vascular events. The moderate 
but significant correlation between IMT and Framingham score observed 
in a large population (PARC Study) raises the question of the best 
indicator for vascular event in individuals. IMT measurement is the first 
candidate to evaluate against conventional evaluation of cardiovascular 
risk in prospective studies. Clinical trials aimed to show that the efficacy 
of various classes of drugs on the reduction of IMT translates into the 
reduction of vascular events are needed and are currently underway 
CAROTID INTIMA-MEDIA THICKNESS MEASUREMENTS 
Manual B-mode versus automated Radio-Frequency measurements. 
The approaches to measure CIMT can be classified generally in 
two major Categories: manual versus automated measurements. Manual 
measurement can be subdivided in offline and online measurements. In 
off-line measurements B-mode ultrasound images are stored on videotape 
or a digital medium. The CIMT measurements are performed later, with 
either manual tracing or an automated edge detection program. In routine 
clinical practice this approach may seem elaborate and time-consuming. 
Alternatively, in clinical practice CIMT can be measured manually and 
online with calipers of the ultrasound machine which provides a direct 
estimate of CIMT. Disadvantages of manual measurements are that it can 
be relatively time-consuming. Furthermore reader subjectivity due to 
personal interpretation of the lumen-intima and media-adventitia borders 
on the B-mode image, reflectivity of the structures, gain setting and 
compression characteristics of the ultrasound system are other 
disadvantages. A technically different approach is the M-mode 
ultrasonography, an on-line automated measurement approach which uses 
radiofrequency (RF) signals. In this approach, the diameter and relative 
increase in cross-sectional area are obtained with a wall track system 
which processes the raw RF signals that are received along a single line 
of observation (M-line processing).The RF measurements are performed 
in the distal common carotid artery 2 cm proximal to the origin of the 
carotid bulb . Automated RF is more time efficient and involves a 
minimum of user interaction .RF calculates mean IMT locally over a 
cardiac cycle instead of mean IMT over a 10-mm segment at end-
diastole. With RF simultaneous assessment of arterial wall properties 
such as distensibility can be obtained at the same location, facilitating 
detailed study of the intrinsic wall characteristics Variability in CIMT due 
to sonographers in the RF approach remains but the reproducibility of the 
automated RF approach has been shown to be good, as reported in 
previous studies). 
MEAN OR MEAN MAXIMUM CAROTID INTIMA-MEDIA 
THICKNESS AS PRIMARY OUTCOME IN LIPID LOWERING 
INTERVENTION STUDIES 
 The mean maximum CIMT is a summary measure that is computed 
as the mean of the single maximum CIMT measurements measured in 6 
to 12 standard carotid artery walls (far or near wall of the3 distinct carotid 
segments: the common carotid segment (CCA), the carotid bifurcation 
(BIF) and the internal carotid artery (ICA) segment) at both the left or 
right side. A mean maximum CIMT ultrasound assessment also enables 
the reader to acquire the mean common CIMT measure. The choice for 
one or the other CIMT measure as primary outcome is generally based on 
personal preference and/or expert opinion. An evaluation of the published 
data to support the use of either measure is lacking, but its availability 
may facilitate an evidence based decision. Arguments in favor of a 
common CIMT measurement over a mean maximum CIMT measurement 
generally include higher reproducibility, more complete measurement 
assessment, an equally strong relation with future events, a stronger 
relation between progression rates and lipid levels, a higher susceptibility 
for lipid lowering treatment, and a more rapid ultrasound protocol. 
Support for mean maximum CIMT measurement above common CIMT 
measurement includes the view that reproducibility, completeness, risk 
prediction, and lipid level relations are similar to that of the common 
CIMT, but that a mean maximum CIMT provides a more complete 
coverage of the extent of carotid atherosclerosis. Furthermore, CIMT 
progresses differently over the carotid segments and it appears 
unpredictable at which segment lipid modifying treatment might have its 
effect. In addition, when mean maximum CIMT measurement is chosen, 
also information on the mean common CIMT is collected so one can use 
both the mean maximum CIMT and the mean common CIMT as outcome 
measurement. Based on the literature, reproducibility and lipid relations 
appear similar for both the mean maximum and mean common CIMT 
measurement, but, the mean maximum CIMT results most often are 
congruent with event findings. Therefore, the mean maximum CIMT as 
primary outcome is preferred. An additional advantage is that information 
on mean common CIMT can also be obtained in protocols assessing the 
mean maximum CIMT, but not the other way around. 
ULTRASOUND PROTOCOLS TO MEASURE CAROTID 
INTIMA-MEDIA THICKNESS 
 A comparison of reproducibility, rate of progression and treatment. 
Effect in asymptomatic subjects with mild to moderate sub clinical 
atherosclerosis   the number and specific combination of segments, angles 
and walls interrogated are associated with differences in reproducibility; 
magnitude and accuracy of progression of CIMT over time and treatment 
effect. The best balance between these parameters was found in mean 
maximum CIMT protocols followed by the mean common CIMT 
protocols, that included measurements of both walls at multiple angles. 
Protocols in which only the far wall was measured performed worse than 
protocols in which both the near and far wall were measured. 
COMMON CAROTID INTIMA-MEDIA THICKNESS AND 
ARTERIAL STIFFNESS SMART STUDY  
  In a study by   Petra C. G. Simons et.al. , , Common carotid 
intima-media thickness (IMT) and distensibilityrelationship was studied, 
as markers of structural and functional vessel wall properties Common 
carotid IMT and distensibility are clear markers of cardiovascular risk in 
patients who already have vascular disease or atherosclerotic risk factors. 
IMT appears to discriminate between low- and high-risk patients better 
than distensibility. Arterial stiffness has been described by use of several 
parameters: distensibility coefficient, compliance coefficient,stiffness (ß), 
pressure-strain elastic modulus, Young's modulus, and pulse-wave 
velocity. In most of these parameters, the relationships between 
distensibility (change in lumen diameter), pulse pressure, and carotid 
lumen diameter are included. Riley et al used component mathematical 
models in which diameter change was the dependent variable and pulse 
pressure and lumen diameter were covariates of the predictor variable 
rather than ratios to describe arterial stiffness. Simons have shown that 
there is  no statistically significant associations observed between pulse 
pressure, lumen diameter, and distensibility; therefore, adjustments for 
lumen diameter and pulse pressure were redundant. For IMT, usually no 
adjustments are made for pulse pressure and lumen diameter despite their 
relationships to IMT. Adjustments for pulse pressure and lumen diameter 
may be justified if one wants to study associations with distensibility or 
IMT independent of pulse pressure and lumen diameter.  
There is increasing evidence that increased IMT and decreased 
distensibility are associated with the presence of cardiovascular risk 
factors and cardiovascular disease and that increased IMT is associated 
with higher risk of future myocardial infarction and stroke. Furthermore, 
a positive relationship between IMT and risk scores was also reported for 
the British Heart Study, Framingham, and EPOZ risk scores.. Measures of 
IMT and distensibility may also prove to be useful as markers of 
increased cardiovascular risk in a population with extensive 
cardiovascular disease. Common carotid IMT and distensibility are clear 
markers of cardiovascular risk in patients who already have 
cardiovascular disease or risk factors. Simons study indicates that 
Increased IMT discriminates between low and high-risk patients better 
than reduced distensibility.  
CAROTID Artery Intima -Media Thickness, Plaques, and C 
- reactive protein   With Future Cardiovascular Disease and 
All-Cause   Mortality.51 
 Jie  J. Cao et al ., in The Cardiovascular Health Study  have 
shown that Elevated C-reactive protein (CRP) and increased carotid 
artery intima -media thickness (IMT) are both associated with the 
occurrence of stroke. Higher CRP is also associated with higher IMT,. It is 
not clear whether CRP and carotid IMT each play an independent role in 
the pathogenesis of stroke.  
Inflammation mediates a key role in the pathogenesis of 
atherosclerosis. Various cytokines, growth factors, and inflammatory cells 
are abundant in atheromatous plaques.  The atherosclerotic vessel wall is 
the source of soluble adhesion molecules that mark inflammation. 
Endarterectomy specimens from symptomatic patients compared with 
asymptomatic patients and those in areas with more extensive plaques 
have higher expression of adhesion molecules. Thus, the extent of 
inflammation may reflect in part the propensity of atherosclerotic lesions 
to lead to clinical disease.  
It appears that among inflammation-sensitive proteins studied to 
date in relation to cardiovascular disease risk, higher CRP concentration 
is most consistently and strongly related to risk.  Higher CRP might be a 
marker of destabilizing plaques, and CRP itself might also participate in 
plaque destabilization. It has been proposed that CRP reflects the overall 
inflammatory burden of atherosclerotic disease However, there is also 
evidence for possible direct roles of CRP in the pathogenesis of 
atherosclerosis, such as induction of endothelial cell adhesion molecules, 
opsonization of native LDL to form foam cells, induction of monocyte 
tissue factor production, and recruitment of monocytes by receptor-
mediated chemotaxis.  
And from this study it is clear that CRP is a risk factor for stroke 
independent of carotid IMT and, because it might be a marker of plaque 
severity and instability, that CRP would be more strongly related to stroke 
among those with higher carotid IMT. in the Cardiovascular Health 
Study (CHS). Elevated CRP is related to the future occurrence of 
ischemic stroke in this elderly cohort, an association that is largely 
independent of atherosclerosis severity as measured by carotid IMT. The 
association of CRP with stroke was less apparent among those with less 
advanced compared with more advanced carotid atherosclerosis. 
Although CRP and carotid IMT are closely correlated, each factor may 
be an independent integral in the risk of ischemic stroke. There is a trend 
to suggest that the association of CRP and stroke might be stronger in 
men than in women. These findings should be further explored both in the 
laboratory and in ongoing observational and interventional studies carotid 
IMT, plaque, and elevated CRP each independently contributed to the risk 
of CVD and all-cause mortality in models that included all 3 measures. 
However, elevated CRP was associated with CVD events and all-cause 
mortality only in those with detectable atherosclerosis. Addition of CRP 
or carotid atherosclerosis to conventional risk factors resulted in a modest 
increase in the ability to predict CVD on the basis of ROC analysis. 
CAROTID INTIMAL-MEDIAL THICKNESS AND CORONARY 
CALCIFICATION 33   
 
 Patricia H. Davis et al studied   the noninvasive methods used to 
evaluate early carotid and coronary atherosclerosis that included 
measurement of carotid intimal-medial thickness (IMT) by B-mode 
ultrasound and detection of coronary artery calcification (CAC) by 
electron beam computed tomography (EBCT). Presence of calcification in 
the coronary arteries has been correlated with atherosclerotic changes in 
the coronary arteries found on postmortem examination or coronary 
angiography. CAC has also been shown to be associated with known risk 
factors for CAD in adults. Their study provides new data concerning the 
distribution of carotid IMT in a cohort aged 33 to 42 years and the 
association between increased carotid IMT and CAC. Most 
epidemiological studies of risk factors for atherosclerosis and clinical 
trials for the prevention of disease have used the morbidity and mortality 
that results from coronary artery disease (CAD), stroke, and peripheral 
vascular disease as measures of the disease process in older adults. There 
is a need to identify young subjects at risk for premature cardiovascular 
disease so that preventive measures may be instituted before occlusive 
vascular disease occurs. In this study, the investigators have used 
noninvasive measures of carotid and coronary artery atherosclerosis to 
evaluate the early process in young asymptomatic adults and to examine 
the relationship to established cardiovascular risk factors. Presence of 
calcification in the coronary arteries has been correlated with 
atherosclerotic changes in the coronary arteries found on postmortem 
examination or coronary angiography. CAC has also been shown to be 
associated with known risk factors for CAD in adults. Increased carotid 
IMT is also associated with known cardiovascular risk factors in older 
adults, as well as with prevalent and incident CAD. In addition, small 
case-control studies have shown increased carotid IMT in children with 
familial hypercholesterolemia. Since 1971, a cohort of children in 
Muscatine, Iowa, has been followed up, with risk factors measured in 
childhood (ages 8 to 18 years) and young adulthood (ages 20 to 33 years). 
In a prior study of this cohort, Mahoney et al demonstrated that in 197 
men and 187 women aged 29 to 37 years, CAC was associated with 
concurrently measured body mass index (BMI), blood pressure, and low 
HDL cholesterol (HDL-C), as well as with BMI measured in childhood 
Cardiovascular risk factors are associated with increased carotid IMT in 
adults aged 33 to 42 years. An association between carotid IMT and CAC 
that supports the use of carotid ultrasound to identify young adults at risk 
for premature atherosclerosis not only in the carotid arteries but also in 
the coronary arteries. Identification of atherosclerosis at an early age 
could lead to the development of interventions to ameliorate the process 
before the development of symptomatic disease 
 
 
Carotid intima-media thickness by B-mode ultrasound as 
surrogate of coronary atherosclerosis: correlation with 
quantitative coronary angiography and coronary 
intravascular ultrasound findings 
High resolution B-mode ultrasound is a non-invasive technique 
widely used to assess atherosclerosis in superficial arteries. It allows the 
accurate measurement of the distance between blood–intima and media–
adventitia interfaces of the carotid wall, which is defined as carotid 
intima-media thickness (IMT). Several authors have suggested that 
carotid IMT is a marker of atherosclerosis in other vascular beds. Indeed, 
an increased carotid IMT has been associated with a number of 
atherosclerosis risk factors, with the prevalence and extent of coronary 
artery disease (CAD) and with the incidence of new coronary and cerebral 
events. In view of these relationships, carotid IMT has been proposed as a 
surrogate endpoint to be used in clinical trials as an alternative to 
coronary atherosclerosis.  
In spite of the widespread use of carotid IMT as a surrogate for 
CAD, validation studies evaluating the correlation between carotid IMT 
measured by external carotid ultrasound (ECU) and CAD measured by 
quantitative coronary angiography (QCA) showed a relatively poor 
correlation (r < 0.36 on average). This finding has cast doubt on the 
reliability of carotid atherosclerosis as a surrogate marker of coronary 
atherosclerosis. Postmortem studies, however, have shown a far greater 
degree of correlation between the two arterial districts, which suggests 
that the poor correlation observed in ECU vs. QCA studies, may be due 
more to technical issues than to differential effects of the traditional 
vascular risk factors on the carotid and coronary tissues.  
Intravascular ultrasound (IVUS) is a unique imaging modality for 
the direct examination of vessel dimensions and arterial wall 
characteristics in live subjects. Like ECU, IVUS measures, in addition to 
lumen diameter, plaque area and any thickening of arterial walls. Carotid 
and coronary arterial districts can then be compared using the same 
arterial wall parameter, namely the IMT. Studies so far published 
addressing the relationship between IVUS-detected coronary 
atherosclerosis and carotid ultrasonic measurements, carotid IMT was 
correlated with coronary percent plaque area, and the correlation between 
IMT in the two vascular districts was not investigated. Researchers found 
correlations were stronger than those observed in QCA studies and closer 
to those observed in postmortem studies could be obtained by using the 
homogeneous variable IMT. And also found that carotid IMT would 
identify subjects with IVUS-detected evidence of coronary atherosclerosis 
among patients with a QCA diagnosis of no or intermediate coronary 
lesions.  
Ankle-Brachial Index and Sub clinical Cardiac and 
Carotid Disease 37 
Mary McGrae   Mc Dermott et. al. in The  Multi-Ethnic Study of 
Atherosclerosis have shown that Lower-extremity peripheral arterial 
disease (PAD) can be detected non invasively with the ankle-brachial 
index (ABI), a ratio of Doppler-recorded systolic blood pressures in the 
lower and upper extremities. In persons without PAD, arterial pressures 
increase with greater distance from the heart, because of increasing 
impedance with increasing arterial taper, resulting in higher systolic blood 
pressures at the ankle as compared with the brachial arteries. Thus, 
persons without atherosclerosis typically have an ABI greater than 1.00. 
An ABI less than 0.90 is highly sensitive and specific for angiographic 
ally diagnosed PAD   
In general medical practice, the prevalence of ABI <0.90 is 25–30 
percent among patients selected for older age or a history of diabetes or 
smoking. ABI <0.90 is associated with a two- to threefold increased risk 
of cardiovascular morbidity and mortality. The prevalence and 
significance of borderline ABI (i.e., ABI 0.90–0.99), low-normal ABI 
(i.e., ABI 1.00–1.09), and elevated ABI (i.e., ABI 1.30) are less well 
studied. In their study the prevalence of a priori defined categories of 
ABI: PAD (ABI <0.90), borderline ABI (ABI 0.90–0.99), low-normal 
ABI (ABI 1.00–1.09), and normal ABI (ABI 1.10–1.29), and high ABI 
(ABI 1.30) in an ethnically diverse group of men and women 
participating in the Multi-Ethnic Study of Atherosclerosis (MESA). 
Associations between these ABI categories and severity of sub clinical 
atherosclerosis in the carotid and coronary arterial beds. That borderline 
ABI, low-normal ABI, definite PAD, and possibly high ABI would be 
associated with more severe sub clinical atherosclerosis in other vascular 
beds in comparison with normal ABI values. Whether there were ethnic 
differences in associations between ABI and sub clinical atherosclerosis 
in the carotid and coronary arterial beds. Borderline and low-normal ABI 
values were common in the MESA cohort. In both men and women, 
borderline ABI values were associated with a significantly higher 
prevalence of sub clinical atherosclerosis in comparison with normal ABI 
values (ABI 1.10–1.29). Low-normal ABI values were associated with a 
significantly higher prevalence of sub clinical atherosclerosis in men. 
Based on the findings reported here, further study is needed to determine 
whether persons with borderline ABI and men with low-normal ABI have 
a higher incidence of cardiovascular events than persons with normal 
ABI, and whether intensive atherosclerotic risk factor intervention 
comparable to that currently recommended for patients with clinically 
evident PAD is important for persons with borderline and low-normal 
ABI in order to prevent the progression of subclinical atherosclerosis 
Glycated Hemoglobin Level is strongly related to the 
Prevalence of Carotid Artery Plaques with High 
Echogenicity in Non diabetic Individuals 36 
 In The Tromso Study   HbA1c , an indicator of average glycemia 
over the previous 6 to 8 weeks was correlated with CMIT. THE level of 
HbA1c has been suggested as a diagnostic or screening tool for diabetes. 
Previous studies have shown that HbA1c concentration is related to 
mortality and cardiovascular disease in non diabetic persons. In this 
population-based study examined the prevalence of carotid artery plaques, 
with emphasis on plaque morphology, in subjects at different HbA1c 
levels. Increasing HbA1c levels are related to an increased risk of carotid 
artery plaques and that the relationship depends on plaque echogenicity. 
And the results suggest that the degree of glycemia contributes to the 
development of hard echogenic plaques and that the process takes place 
already at modestly elevated levels of HbA1c. 
Association of increased carotid intima-media thickness with 
the extent of coronary artery disease  
A Kablak-Ziembicka et al.32., in their study  have shown  A 
significant correlation between mean IMT and advancing CAD (p < 
0.0001). Four independent predictors of CAD were found in the 
discriminant analysis: age (p = 0.0193), hyperlipidaemia (p < 0.0001), 
smoking (p = 0.0032), and IMT (p < 0.0001). A significant increase in 
IMT was observed among patients with one, two, and three vessel CAD. 
A log normal distribution of IMT values showed that if mean IMT was 
over 1.15 mm, patients had a 94% probability of having CAD, with 
sensitivity of 65% and specificity of 80% in the patients with a high risk 
of CAD. The number of critically stenosed   extra cranial arteries 
increased with advancing CAD. None of the patients with normal 
coronary arteries had severe stenosis of the extra cranial arteries. Severe 
carotid, vertebral, or subclavian stenosis was found in 16.6% of patients 
with three vessels CAD 
 Extra cranial Carotid Atherosclerosis 
Progression With Coronary Status and Risk Factors 
in Patients With and Without Coronary Artery 
Disease 53 
 In  the study by Crouse, III, MD et al.. EXTRA CRANIAL CAROTID 
ATHEROSCLEROSIS PROGRESSION WAS STUDIED .Age, sex, hypertension, 
smoking, diabetes, LDL and HDL cholesterol, as well as coronary status 
have been associated with extra cranial carotid disease, and investigators 
have suggested that they impact disease progression. Although direct 
quantification of the influence of risk factors on carotid intimal medial 
thickness (IMT) progression is more accurate than inference from cross-
sectional studies, it also represents a greater technological challenge, 
because IMT changes slowly. Several epidemiological investigations 
have reported on IMT progression. This study compared progression in 
patients with and without coronary artery disease (CAD). It is clear from 
this study that patients with angiographic evidence for CAD would 
experience more rapid progression of carotid IMT than CAD-free 
individuals.  
COMMON CAROTID INTIMA-MEDIA THICKNESS AND RISK 
OF STROKE AND MYOCARDIAL INFARCTION 45 
 In The Rotterdam Study Michiel L. Bots, MDet.al., have 
demonstrated increased common carotid intima-media thickness relates to 
future cardiovascular and cerebrovascular events. This study provides 
supportive evidence for the use of intima-media thickness measurements 
as an intermediate or proxy end point in observational studies and trials 
Common Carotid Artery Intima-Media Thickness 
and Brain Infarction 45 
Carotid ultrasonographic methods capable of visualizing the 
arterial wall have been used to obtain measures of intima-media thickness 
(IMT). Increased IMT is generally considered an early marker of 
atherosclerosis. Cross-sectional associations have been reported between 
IMT and cardiovascular risk factors, prevalent cardiovascular disease, 
and peripheral atherosclerosis. Many prospective studies showed that an 
increased carotid IMT was associated with an increased risk of incident 
myocardial infarction. Two studies also showed that an increased carotid 
IMT was associated with an increased risk of stroke.. the authors in this 
study distinguished brain infarction (BI) from hemorrhages It has been 
suggested that IMT may, in part, reflect an adaptive response to changes 
in tensile and shear stress, we also studied IMT in association with CCA 
lumen diameter.; this study  clearly demonstrate that the relation between 
cerebrovascular disease and IMT was not linear, with a significant 
association only present for the highest IMT values  .In the 
Cardiovascular Health Study, 4476 participants ( 65 years) were followed 
for a median duration of 6 years; 284 strokes were ascertained. An 
association between increased IMT and the risk of incident stroke was 
observed. The relative risk increased in a linear fashion with increasing 
IMT, and it was of the same magnitude as the relative risk for myocardial 
infarction this study shows a highly significant association between BI 
and CCA-IMT in the atherothrombotic group. The relation between CCA-
IMT and BI remained after adjustment for main cardiovascular risk 
factors. is likely that an adjustment for lumen diameter is insufficient to 
adjust for wall stress; other measures (i.e., tensile stress and CCA end-
diastolic lumen diameter) may be more meaningful. And it has been 
clearly shown that an increased CCA-IMT was associated with BI, both 
overall and in its main subtypes. Use of IMT as an outcome measure in 
observational studies and intervention trials relies on the view that IMT is 
a marker of atherosclerosis and reflects cardiovascular risk.  
CAROTID INTIMA-MEDIA THICKNESS IS ASSOCIATED 
WITH PREMATURE PARENTAL CORONARY HEART 
DISEASE 43 
A family history of premature coronary heart disease (CHD) is an 
independent risk factor for cardiovascular events. The mechanisms 
underlying this familial clustering have not been established, but may 
include an increased susceptibility to atherosclerosis, an increased 
tendency for thrombosis, or other factors. Important insight may be 
gained by understanding how offspring of parents with premature CHD 
differ from offspring of parents without premature CHD. Evidence 
supporting a higher burden of sub clinical atherosclerosis in individuals 
with a parental history of premature CHD would implicate pathways 
involved in atherogenesis and point to the potential utility of sub clinical 
disease measures as "intermediate phenotypes" for mapping CHD 
susceptibility genes. Elucidating this association may also have clinical 
implications, because it has been suggested that asymptomatic adults with 
a positive family history may benefit from sub clinical disease screening 
to determine need for primary preventive therapies. 
High-resolution carotid ultrasound provides a noninvasive 
assessment of atherosclerotic burden. Increased intima-media thickness 
(IMT) is associated with prevalent coronary heart disease, peripheral 
vascular disease, and incident cardiovascular events. There is also 
evidence that carotid IMT may be a heritable trait. An association 
between carotid IMT or plaque and a parental history of CHD has been 
studied in one hospital-based study and several community-based studies. 
The Framingham Heart Study provides an opportunity to study the 
association between parental history and offspring sub clinical 
atherosclerosis, using a population-based cohort of families in which 
CHD events have been validated prospectively in both parents and 
offspring. It is also possible to examine whether this association is 
modified by parental sex or age of disease onset, offspring sex, or 
offspring cardiovascular disease risk factors 
 Thomas J. Wang, MD and colleagues performed ultrasound of the 
common carotid and brachial arteries in 40 offspring (mean age 19 years) 
recruited from patients hospitalized with premature acute myocardial 
infarction. Compared with age- and sex-matched controls, the offspring 
had increased common carotid IMT and more abnormalities in brachial 
artery reactivity. Whtey et.al., found an association between parental 
premature CHD and offspring carotid IMT in this large, prospective 
family-based cohort. Their  results and those of prior studies strongly 
support the existence of anatomic and functional vascular abnormalities in 
offspring of parents with premature CHD, independent of known vascular 
risk factors. Further investigation may help to clarify the relative 
contribution of shared genetic background versus shared environmental 
influences to this familial predisposition. In this regard, carotid IMT may 
be a useful phenotype for the study of the genetic transmission of CHD 
CAROTID INTIMA-MEDIA THICKNESS AND 
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE 
INHIBITORS.40 
 Allen J. Taylor, MD et.al. ,, compared the Effects of Atorvastatin 
and Pravastin on IMT . Marked LDL reduction to values substantially 
below 100 mg/dL treatment with atorvastatin provides superior efficacy 
for atherosclerosis regression in the distal common carotid artery at 1 year 
compared with an LDL of 110 mg/dL achieved with pravastatin. This 
early effect on CIMT, a surrogate for clinical benefit of cholesterol 
lowering therapies, supports the hypothesis currently being tested in 
ongoing randomized clinical trials that marked LDL reduction with 
synthetic statins may provide enhanced reduction in clinical coronary 
event rates. statin on Carotid Intima Medial Thickness.  
 Effect of Supplementary Antioxidant Vitamin Intake 
on Carotid Arterial Wall Intima-Media Thickness in a 
Controlled Clinical Trial of Cholesterol Lowering.44 
 There is accumulating experimental, epidemiological, and clinical 
evidence of an association between antioxidant vitamin intake and 
reduced risk of coronary heart disease. Using data from the Cholesterol 
Lowering Atherosclerosis Study (CLAS), the association of self-selected 
supplementary antioxidant vitamin intake on the rate of progression of 
early preintrusive atherosclerosis Supplementary vitamin E intake appears 
to be effective in reducing the progression of atherosclerosis in subjects 
not treated with lipid-lowering drugs while the process is still confined to 
the arterial wall (early preintrusive atherosclerosis).  
Elevated Carotid Artery Intima-Media Thickness Levels in 
Individuals Who Subsequently Develop Type 2 Diabetes  
 Although previous studies have established that coronary heart 
disease (CHD) risk factors are elevated before the clinical onset of 
diabetes and a recent study has reported increased cardiovascular disease 
risk before the clinical onset of diabetes, documented. Documenting not 
only increased cardiovascular risk factors but increased atherosclerosis.  
 Results from the current study suggest again that increased 
atherosclerosis is responsible for elevated cardiovascular disease before 
the onset of clinical diabetes. If, THIS STUDY suggest, the association 
between diabetes and CHD stems mainly from common antecedents, one 
way to prevent the development of atherosclerosis would be to identify 
and intervene in those at high risk of developing diabetes.  
EVIDENCE OF CAROTID ARTERY WALL HYPERTROPHY IN 
HOMOZYGOUS HOMOCYSTINURIA  
 Jean- Louis Megnien, MDet.al.,., have shown that Homozygous 
homocystinuria was associated with common carotid wall hypertrophy, 
whereas heterozygous disease was not. Such hypertrophy may reflect a 
smooth muscle proliferation induced by hyperhomocysteinemia and 
represent a promising target for testing vascular effects of therapeutic 
measures to lower homocysteine 
.DIETARY ANTIOXIDANTS AND CAROTID ARTERY WALL 
THICKNESS  
 Stephen B. Kritchevsky,41 PhD in the The ARIC Study have 
shown that dietary antioxidants may prevent atherosclerotic disease. The 
relationship between the intake of dietary and supplemental vitamin C, 
tocopherol, and provitamin A carotenoids and average carotid artery wall 
thickness was studied in 6318 female and 4989 male participants 45 to 64 
years old in the Atherosclerosis Risk in Communities Study. These data 
provide limited support for the hypothesis that dietary vitamin C and 
tocopherol may protect against atherosclerotic disease, especially in 
individuals >55 years old. 
 Intermediate-Density Lipoproteins and Progression of 
Carotid Arterial Wall Intima-Media Thickness53 
 Howard N. Hodiset.al .., in the Monitored Atherosclerosis 
Regression Study (MARS). Provide data that further give evidence for 
the role of triglyceride-rich lipoproteins in the progression of 
atherosclerosis and support the evidence that indicates that the risk of 
atherosclerosis attributable to LDL-C may in part be the result of 
lipoproteins in the IDL fraction (Sf 12 to 20) that is included within the 
traditional measurements of LDL-C.  
ASSOCIATION OF MENOPAUSE AND HORMONE 
REPLACEMENT THERAPY WITH CAROTID ARTERY INTIMA-
MEDIA 44  
 Atherosclerotic CVD is the major cause of morbidity and mortality 
in older women. Although the incidence of CVD increases with age, 
evidence that natural menopause is an independent risk factor for CHD or 
strokes not convincing. In contrast, several studies have suggested that 
surgical menopause (bilateral oophorectomy) increases CHD risk. HRT 
appears to afford protection from CHD, especially in women with 
bilateral oophorectomy, but there was little evidence that HRT prevents 
stroke until several recent studies were reported. This study evaluated the 
effect of stroke risk, cmit in postmenopausal women and found a 
significant reduction in CMITand stroke risk reduction on HRT therapy   
LOW-DOSE METOPROLOL CR/XL AND FLUVASTATIN SLOW 
PROGRESSION OF CAROTID INTIMA-MEDIA THICKNESS 39 
 Incidence of cardiovascular events in both secondary and primary 
prevention trials has been reduced by statins. The objective of the 
placebo-controlled ß-Blocker Cholesterol-Lowering Asymptomatic 
Plaque Study (BCAPS) by B. Hedblad, MD, PhD et .al ..,.was to 
evaluate the effect of bet blocker on CMIT. Main Results From the ß-
Blocker Cholesterol-Lowering Asymptomatic Plaque Statins reduce 
cardiovascular events and progression of carotid intima-media thickness 
(IMT). ß-Blockers are also known to reduce cardiovascular events, but 
less is known about their effects on carotid IMT.study (BCAPS) this is 
the first randomized trial to show that a ß-blocker can reduce the rate of 
progression of carotid IMT in clinically healthy, symptom-free subjects 
with carotid plaque. This suggests that ß-blockers may have a favorable 
effect on atherosclerosis development. 
INCREASED CAROTID ARTERY INTIMAL-MEDIAL 
THICKNESS IN ASYMPTOMATIC OLDER SUBJECTS WITH 
EXERCISE-INDUCED MYOCARDIAL ISCHEMIA 50 
 Asymptomatic coronary artery disease (CAD) is prevalent in the 
general population, and individuals with CAD are at greater risk than 
those who are disease free to progress to symptomatic CAD and cardiac 
death. Yoji Nagai, MD et. al., in their study have shown CCA IMT is 
increased in older subjects with asymptomatic myocardial ischemia as 
evidenced by exercise ECG alone or in combination with thallium scan. 
Carotid ultrasound may help to identify asymptomatic individuals with 
CAD  
 
 
 
 
 
 MATERIALS AND METHODS 
 CAROTID artery lumen diameter, IA diameter, and intima-media 
thickness (IMT) were measured using B-mode ultrasound ALOKA 
prosound SSD 4000 machine with a 7.5 MHz probe in the common and 
internal carotid arteries of 123 CAD case patients and 125 disease-free 
control subjects. All patients have undergone CAG for evaluation CAD 
study was done strictly adhering to study protocol at the department of 
cardiology government Stanley medical college. Study was done after 
getting approval from local ethics committee 
EXCLUSION CRITERIA  
1. Patients with coronary   stenoses of <50% were excluded 
2. Patients were excluded who were alcohol, drug abusers  
3. Clinically unstable Patients 
4.  Previous   coronary bypass surgery, angioplasty, or carotid 
endarterectomy. 
5. Controls who were on medications lipid-lowering drugs, thyroid 
medication, or cortisone  
6. Patients who have hepatic disease,  cancer, or renal failure.  
CLINICAL EVALUATION 
1. Medical history  
2. Vascular disease risk factors 
3. Menopausal status 
4. Medication   
5. Height, weight, and blood pressure 
STUDY PROTOCOL 
1. Informed consent          
2. ECHO cardiographic evaluation 
3. Selection of cases with optimal images       
4. Lipid profile 
5. Symptom limited exercise Stress test                  
6. Patients underwent Coronary angiogram in our cath lab 
Risk Factors in Patients With CAD and in CAD-Free Control 
Subjects 
Risk Factors in Patients With CAD and in CAD-Free Control Subjects 
 All Patients Male Patients (n=124) Female Patients (n=124) 
 
CAD 
Cases 
(n=123) 
Disease-
Free 
Control 
Subjects 
(n=125) 
P 
CAD 
Cases 
(n=61) 
Disease-
Free 
Control 
Subjects 
(n=63) 
P 
CAD 
Cases 
(n=61) 
Disease-
Free 
Control 
Subjects 
(n=63) 
P 
TC, 
mg/dL 
217±39 207 ±39 0.037 207±37 196 ±37 0.084 227±39 217±38 0.17 
TG, 
mg/dL 
185±109 177±149 0.618 181±108 179 ±145 0.922 189±11
1 
175±155 0.541
HDL, 
mg/dL 
43 ±12 47±16 0.016 38±11 41±16 0.23 47±12 52 ±14 0.017
LDL, 
mg/dL 
141±32 130±34 0.006 135 ±31 123±33 0.02 146±33 136±33 0.1 
Smoking, 
pk-y 
25±31 19±25 0.045 36±33 28±29 0.154 15 ±25 9±17 0.112
DM, % 22 9 0.002 14 6 0.102 30 11 0.007
HTN, % 53 41 0.041 42 32 0.001 64 50 0.088
Age, y 62±8 56±8 0.001 61±7 56 ±9 0.002 63±9 56±7 0.001
 
The data shows the risk factor profile of  cases and controls  
METHODOLOGY 
 Arterial IMT and dimensions were measured with ALOKA 
prosound SSD4000, 7.5 MHZ probe. For the present analysis, 2 carotid 
segments were identified on both the left and right sides: the distal 1 cm 
of the common carotid proximal to the bifurcation and the proximal 1 cm 
of the internal carotid. 2 interfaces were identified on each wall: on the 
near wall, the first interface (interface 2) is the adventitial-medial 
boundary, and the second (interface 3) is the intima-lumen boundary; on 
the far wall, the first interface (interface 4) is the lumen-intima boundary, 
and the second (interface 5) is the media-adventitia boundary. Thus, 2 to 3 
and 4 to 5 define IMT on the near and far walls, respectively. Examiner 
optimized the near and far walls separately (multiple focus zones) to 
define the maximum IMT for each of the 8 sites.  
 Arterial dimensions were measured at the maximum 2 to 3 or 4 to 5 
IMT within each segment. Reference points were placed at interfaces 2, 3, 
4, and 5 when available, and the distance was computed between 
interfaces 2 and 3 (near-wall IMT), 4 and 5 (far-wall IMT), 3 and 4 
(lumen), and 2 and 5 (interadventitial [IA] diameter). In some cases, 
because of the tortuosity of the internal segment, the intima/lumen 
interface (interface 3 or 4) opposing the site of maximum IMT could not 
be visualized and direct lumen measurement was not possible. If 
interfaces adjacent to this site (with missing intima/lumen interface) were 
defined,  we measured the IMT there after recording the maximum IMT 
and IA diameter measurements. In such circumstances, an indirect 
measurement of lumen diameter was computed by subtracting the 
adjacent IMT plus the maximum IMT from the IA diameter measured at 
the maximum IMT site 
STATISTICAL METHODS 
 Preliminary analyses suggested no differences in the distributions 
of IMT, lumen diameter, and IA diameter for right versus left carotid 
artery; therefore, the mean of right- and left-side measures was analyzed 
for each variable. For data presentation and analysis, age and IMT were 
categorized separately into quartiles by ranking these data without regard 
to CAD status. General linear regression models (SAS GLM procedure) 
were used to test associations between arterial dimensions and case-
control status, age quartile, and IMT quartile. For arterial measures, 
means and SEMs (SAS least-square means procedure) are reported after 
adjustment for age, sex, and, where appropriate, IMT. Because physical 
stature is known to contribute to arterial diameter, height was included in 
all multivariable models for arterial dimensions.  
 
 
RESULTS AND DATA ANALYSIS 
The age was associated with structural measures (IMT, IA 
diameter, and lumen diameter) similarly in CAD cases and controls with 
the exception of the association between age and internal carotid lumen 
diameter.  
Logistic Models to Predict CAD Status as a Function of Age and Each of 
the 11 Segment-Specific and Aggregate IMT Measures 
Probability of 
Correct Class 
Model ß SEM (ß) x2 P 
Median 
Inner-
Quartile 
Range 
ALL PATIENTS 
Mean common 2.411 0.545 23.37 <.001 0.607 0.29 
Mean 
bifurcation 
1.595 0.305 34.06 <.001 0.648 0.31 
Mean com/bif 2.679 0.514 34.4 <.001 0.639 0.31 
Mean bif/int 1.946 0.384 33.05 <.001 0.64 0.31 
Mean internal 1.327 0.318 21.55 <.001 0.602 0.26 
Mean agg 2.631 0.499 35.77 <.001 0.649 0.31 
Mean agg far 
wall 
1.854 0.38 30.78 <.001 0.638 0.3 
Max common 0.767 0.194 18.49 <.001 0.608 0.28 
Max bifurcation 0.751 0.162 24.82 <.001 0.613 0.29 
Max internal 0.699 0.176 18.46 <.001 0.597 0.26 
Max agg 0.738 0.156 25.84 <.001 0.625 0.29 
MALE PATIENTS 
Probability of 
Correct Class 
Model ß SEM (ß) x2 P 
Median 
Inner-
Quartile 
Range 
Mean common 2.308 0.735 11.5 0.001 0.596 0.3 
Mean 
bifurcation 
1.301 0.382 13.35 <.001 0.621 0.3 
Mean com/bif 2.325 0.66 14.88 <.001 0.62 0.29 
Mean bif/int 1.828 0.506 16.09 <.001 0.645 0.29 
Mean internal 1.573 0.442 16.14 <.001 0.643 0.27 
Mean agg 2.413 0.637 17.77 <.001 0.646 0.33 
Mean agg far 
wall 
1.557 0.492 12.16 <.001 0.608 0.26 
Max common 0.618 0.249 6.93 0.009 0.588 0.24 
Max bifurcation 0.5 0.2 6.73 0.009 0.592 0.26 
Max internal 0.696 0.233 10.4 0.001 0.567 0.42 
Max agg 0.461 0.193 6.1 0.013 0.595 0.25 
 
FEMALE PATIENTS 
 
Mean common 2.507 0.826 11.28 0.001 0.613 0.3 
Mean 
bifurcation 
2.054 0.521 21.42 <.001 0.656 0.31 
Mean com/bif 3.209 0.844 19.52 <.001 0.655 0.31 
Mean bif/int 2.098 0.601 16.59 <.001 0.636 0.32 
Mean internal 1.025 0.467 5.71 0.017 0.574 0.25 
Mean agg 3.004 0.823 17.72 <.001 0.65 0.33 
Mean agg far 
wall 
2.228 0.602 18.91 <.001 0.658 0.33 
Max common 0.974 0.316 12.04 <.001 0.622 0.3 
Max bifurcation 1.152 0.288 21.19 <.001 0.665 0.31 
Max internal 0.704 0.278 7.61 0.006 0.585 0.26 
Max agg 1.171 0.275 23.84 <.011 0.687 0.3 
 
Among all participants, both common and internal carotid IMTs 
were greater in each quartile of increasing age (P<0.01 for each artery 
segment, adjusted for CAD status). In the common carotid artery, both 
lumen and IA diameter were greater in association with age (P=0.003 and 
P<0.001, respectively, adjusted for CAD status and height). Associations 
of age with common carotid lumen or IA diameter did not differ by case 
status (tests of CAD status–by-age interactions were not significant). In 
contrast, internal carotid IA diameter was not associated with age (P=0.17 
adjusted for CAD status and height), whereas lumen diameter was smaller 
in older individuals (P=0.002), and the association varied by CAD case 
status (Interaction=0.005). 
 
 
 
 
 
 
 
 
 
 
 
ASSOCIATIONS OF ARTERIAL DIMENSIONS WITH AGE AND 
CAD.  
The following Data shows that, among all participants, height-
adjusted common carotid IA diameter was greater in CAD cases than 
controls (P=0.004), whereas lumen diameters did not differ between cases 
and controls Overall, CAD cases had reduced internal carotid lumen and 
IA diameters compared with controls (P<0.001 and P=0.01, respectively) 
despite markedly greater IMT in the former. 
Arterial Measures in mean Mean±SEM for CAD Cases and Controls 
by Quartiles of Age 
Internal 
45–51 (55 
Controls; 15 
Cases 
52–59 (35 
Controls; 
35 Cases) 
60–65 (32 
Controls; 38 
Cases) 
66–79 (17 
Controls; 53 
Cases) 
P P for 
age 
trend 
P P for 
age-by–
case status 
interaction 
All 
Participants 
(123 Controls; 
125 Cases) 
 Lumen         
    All 6.53±0.17 6.70±0.15 6.00±0.15 5.94±0.16 0.002 0.005  
    Controls 6.87±0.16 6.74±0.21 6.32±0.23 7.04±0.33 0.41  6.75±0.12 
    Cases 6.22±0.29 6.72±0.20 5.49±0.20 5.33±0.19 <0.001  5.93±0.11 
    P 0.06 0.95 0.01 <0.001   <0.001 
IA        
    All 8.15±0.16 8.43±0.13 7.93±0.13 8.04±0.15 0.17 0.44  
    Controls 8.28±0.14 8.49±0.19 8.15±0.19 8.30±0.30 0.89  8.30±0.10 
    Cases 8.10±0.26 8.40±0.18 7.54±0.17 7.67±0.17 0.05  7.93±0.10 
    P 0.55 0.74 0.02 0.08   0.01 
IMT        
    All 0.99±0.07 1.13±0.06 1.22±0.06 1.36±0.07 0.01 0.4  
    Controls 0.91±0.04 0.93±0.09 1.12±0.10 1.12±0.15 0.04  0.99±0.05 
    Cases 1.07±0.08 1.34±0.09 1.31±0.09 1.53±0.08 0.03  1.37±0.04 
    P 0.1 0.003 0.17 0.02   <0.001 
 
 
 
The relationships between arterial diameters and case status were 
essentially unaffected by adjustment for age and sex (data not shown). In 
the internal carotid, associations of prevalent CAD with smaller IA and 
lumen diameters persisted (P<0.01 and P<0.001, respectively) in 
multivariable models that included age, sex, and IMT. 
Arterial Measures in mean Mean±SEM for CAD Cases and Controls 
by Quartiles of Age 
Common 
45-51 (55  
Controls;  
15 Cases) 
52-59 (35  
Controls;  
35 Cases) 
60-65  
(32 Controls;  
38 Cases) 
66-79 (17  
Controls;  
53 Cases) 
PP for  
age trend 
PP for age-
by-case 
status 
interaction 
All participants (123 
controls;  
125 Cases) 
Lumen        
    All 6.00±0.11 5.89±0.09 6.18±0.09 6.32±0.10 0.003 0.88  
    Controls 5.98±0.09 5.85±0.11 6.05±0.13 6.30±021 0.006  6.05±0.07 
    Cases 6.08±0.18 6.06±0.11 6.20±0.12 6.32±0.12 0.12  6.16±0.07 
   P 0.64 0.17 0.38 0.92   0.23 
IA        
    All 7.67±0.11 7.67±0.10 8.11±0.10 8.38±0.12 <0.001 0.8  
    Controls 7.53±0.11 7.53±0.13 7.86±0.14 8.25±0.24 <0.001  7.80±0.08 
    Cases 7.87±0.21 7.97±0.13 8.24±0.13 8.41±0.13 0.03  8.12±0.13 
    P 0.17 0.02 0.06 0.56   0.004 
IMT        
    All 0.86±0.03 0.94±0.03 0.99±0.03 1.07±0.03 <0.001 0.52  
    Controls 0.84±0.02 0.86±0.04 0.96±0.04 1.04±0.07 <0.001  0.90±0.02 
    Cases 0.88±0.04 1.02±0.04 1.03±0.04 1.11±0.04 0.03  1.04±0.02 
    P 0.26 0.01 0.17 0.36   <0.001 
 
CASE-CONTROL DIFFERENCES IN  
ARTERIAL DIMENSIONS 
Height-adjusted common carotid IA diameter was greater in CAD 
cases than controls (P=0.004), whereas lumen diameters did not differ 
between cases and controls. Overall, CAD cases had reduced internal 
carotid lumen and IA diameters compared with controls (P<0.001 and 
P=0.01, respectively) despite markedly greater IMT in the former The 
internal carotid, associations of prevalent CAD with smaller IA and 
lumen diameters persisted (P<0.01 and P<0.001, respectively) in 
multivariable models that included age, sex, and IMT.  
Arterial dimensions CAD Cases and Controls by severity of 
coronary artery disease 
Height-adjusted common carotid IA diameter was greater in triple 
vessel disease than in patients with single vessel disease (P=0.01), 
whereas lumen diameters did not differ between 3vessel Disease and 
1vessel  Disease. Overall, 3 VD cases had reduced internal carotid lumen 
and IA diameters compared with controls (P<0.01 and P=0.02, 
respectively) despite markedly greater IMT in the former the internal 
carotid, associations of prevalent CAD with smaller IA and lumen 
diameters persisted (P<0.01 and P<0.001, respectively) in multivariable 
models that included age, sex, and IMT.  
 
The following data shows the relation ship between carotid artery 
dimensions and severity of coronary artery disease 
Arterial Measures (mm)in Mean±SEM for CAD Cases and Controls by severity 
of coronary artery disease 
CAG single vessel 
disease= 38 
double vessel 
disease=43 
Triple  vessel T 
disease N=42 
Common Lumen    
    Controls 5.98±0.09 5.85±0.11 6.05±0.13 
    Cases 6.08±0.18 6.06±0.11 6.20±0.12 
   P 0.64 0.17 0.38 
IA    
    Controls 7.53±0.11 7.53±0.13 7.86±0.14 
    Cases 7.87±0.21 7.97±0.13 8.94±0.13 
    P 0.17 0.02 0.01 
IMT    
    Controls 0.84±0.02 0.86±0.04 0.96±0.04 
    Cases 0.88±0.04 1.02±0.04 1.03±0.04 
    P 0.26 0.01 0.17 
 
Arterial Measures (mm)in Mean±SEM for CAD Cases and Controls by severity 
of coronary artery disease  
 
CAG single vessel disease 
Double vessel 
disease Triple  vessel disease 
Internal Lumen    
    Controls 6.87±0.16 6.74±0.21 6.32±0.23 
    Cases 6.22±0.29 6.72±0.20 5.49±0.20 
    P 0.06 0.95 0.01 
IA    
    Controls 8.28±0.14 8.49±0.19 8.15±0.19 
    Cases 8.10±0.26 8.40±0.18 7.54±0.17 
    P 0.55 0.74 0.02 
IMT    
    Controls 0.91±0.04 0.93±0.09 1.12±0.10 
    Cases 1.07±0.08 1.34±0.09 1.31±0.09 
    P 0.1 0.003 0.17 
 
ASSOCIATION OF LUMEN AND IA DIAMETER WITH IMT 
 
The relationships  between IMT and lumen and IA diameters in the 
common and internal carotid arteries, respectively. Demonstrates that 
age- and height-adjusted common carotid IA diameters were larger with 
each quartile of increasing IMT in both cases and controls. Common 
carotid IA diameter was strongly associated with IMT (P<0.001 for age, 
height, and CAD status–adjusted model), and the association was 
consistent in cases and controls (P=0.79 for case status by IMT 
interaction). The marginally significant association of common carotid 
lumen diameter with increased IMT (P=0.06) likewise did not vary by 
CAD status (Interaction=0.98).  
 
Mean Segment-Specific IMT in Patients With CAD and in CAD-Free 
Control Subjects 
  
All Patients 
T P 
Male Patients 
T P 
Female Patients 
T P 
IMT 
measure             
Mean 
common 
1.221± 
0.025 
1.049 ± 
0.025 
4.82 <.001 1.238 ± 
0.034 
1.068 ± 
0.035 
3.37 <.001 1.199 ± 
0.035 
1.032± 
0.034 
3.3 0.001 
Mean 
bifurcation 
1.742± 
0.045 
1.357 ± 
0.045 
5.84 <.001 1.761± 
0.064 
1.416 ± 
0.065 
3.7 <.001 1.717± 
0.064 
1.302 ± 
0.063 
4.5 <.001 
Mean 
bifurcation 
+ common 
1.368 ± 
0.027 
1.135± 
0.027 
5.85 <.001 1.394± 
0.039 
1.175 ± 
0.040 
3.85 <.001 1.336± 
0.038 
1.099 ± 
0.038 
4.3 0.001 
Mean 
bifurcation 
+ internal 
1.465 ± 
0.037 
1.154± 
0.038 
5.72 <.001 1.491± 
0.052 
1.184 ± 
0.053 
3.99 0 1.434± 
0.053 
1.126 ± 
0.053 
4 <.001 
Mean 
internal 
1.320± 
0.044 
1.028 ± 
0.044 
4.57 <.001 1.410± 
0.062 
1.050 ± 
0.063 
3.97 <.001 1.214± 
0.061 
1.011 ± 
0.059 
2.3 0.021 
 
 As suggested by the above data, internal carotid IA diameter was 
not associated with IMT (P=0.27 for age, height, and CAD status–
adjusted model). However, internal carotid lumen diameter was smaller in 
individuals with greater IMT (P<0.01 for age, height, and CAD status–
adjusted model). The trend was present in CAD cases and controls alike, 
with lumen diameter smaller by almost 1 mm in patients in the lowest 
compared with those in the highest quartile of IMT (6.53±0.16 versus 
5.59±0.16 mm, P<0.001, in the lowest and highest quartiles, respectively, 
adjusted for age, height, and CAD status). Mean internal carotid lumen 
diameters for CAD cases tended to be smaller than those of controls at 
each IMT cut-point; however, within quartiles, case-control comparisons 
reached significance only in the upper quartile of IMT. Within the 
internal carotid, CAD cases and disease-free controls showed similar 
associations of lumen and IA diameter with IMT (P=0.32 and 0.28 for 
tests of CAD 
DISCUSSION 
 
 
 Segment-specific associations of carotid artery dimensions with 
IMT were reported previously in a cross-sectional analysis of data from 
the population-based ARIC study.3 Common carotid wall thickening in 
the ARIC study was associated with larger IA diameters in both men and 
women; however, there was no significant association between IMT and 
IA diameter in the internal segment.3 The ARIC analysis suggested that 
common carotid lumina were smaller only when mean far wall IMT 
exceeded 1.2 mm (observed in 1.5% of women and 3.2% of men), but 
internal carotid lumina were smaller over a broad range of increasing 
IMT.3  
 Our   study describes segment-specific differences in carotid artery 
lumen and IA dimensions in individuals with obstructive CAD and CAD-
free controls. Although common carotid IMT was greater in CAD cases 
than controls (as previously reported11–13), IA diameters were increased 
proportionately; thus, lumen diameters were similar in CAD cases and 
controls. In the internal carotid, CAD cases also had greater IMT than 
controls, but both lumen and IA diameters of the internal segment were 
significantly smaller in cases than controls.  
 Of interest, Pasterkamp et al15 reported what the authors called 
"paradoxical constriction" of femoral arteries associated with 
atherosclerosis. Their cross-sectional study suggested that stenoses of 
<25% were most often associated with local arterial enlargement in the 
femoral arteries, whereas reduced arterial diameter accompanied more 
significant stenoses.15 A previous longitudinal study using B-mode 
ultrasound also suggested that the absence of compensatory enlargement 
contributed to lumen compromise during rapid focal progression of 
carotid plaques in areas of high hemodynamic forces such as the internal 
carotid.7 The cross-sectional design of the present study does not permit 
us to determine whether case-control differences in internal carotid IA 
diameters accompanied atherosclerosis or whether individuals with CAD 
had smaller internal carotid arteries ab initio.  
 Because previous studies have described associations of age,7,16,17 
sex,3,5,16–18 and physical stature2,7,16–18 with arterial diameters, we adjusted 
for these factors in multivariable models. These covariates explained 
neither the case-control differences in arterial dimensions nor the 
segment-specific associations of IMT with arterial dimensions. Moreover, 
inclusion of IMT in multivariable models failed to explain reduced 
internal carotid lumen and IA diameters associated with prevalent CAD. 
Pasterkamp et al15 also reported that reductions in femoral artery lumen 
and IA diameters were not explained by increased IMT.  
 It has been postulated that variation in the compensatory 
remodeling mechanism could influence individual susceptibility to 
developing symptomatic, obstructive cardiovascular disease.2 Indeed, we 
found that participants with prevalent CAD had smaller mean internal 
carotid lumen and IA diameters than disease-free controls; however, we 
could detect no statistically significant effect of case status on the 
association of IMT with either lumen or IA diameter (P>0.2 for tests of 
interactive effects of case status on association of IMT with lumen and IA 
diameters). It is possible that our sample size limits the statistical power to 
detect interactive effects with case status, although suggest that large 
differences in the association of carotid artery atherosclerosis with arterial 
dimensions are unlikely between CAD cases and controls.  
Anatomic and physiological differences in the carotid segments 
may partially explain segment-specific differences in associations of 
arterial dimensions with IMT. The internal carotid is a muscular artery, 
whereas the common segment is an elastic conducting artery.19 Elastic 
arteries, such as the common carotid, are exposed to relatively high blood 
pressure and laminar blood flow, ostensibly curtailing intima exposure to 
circulating risk factors. Within the internal carotid, turbulent blood flow 
and locally reduced shear stress prevail20 and advanced plaques are more 
frequent. Longitudinal follow-up suggests that procoagulant risk factors 
such as fibrinogen and lipoprotein (a) contribute to rapid focal 
progression of atherosclerosis in the internal carotid, where blood flow is 
turbulent.7 Moreover, these data showed that rapid focal atherosclerosis 
progression within the internal carotid favored lumen narrowing over 
arterial enlargement and lumen preservation.7,8 In both the coronary and 
carotid artery systems, associations between atherosclerosis and lumen 
and IA dimensions are probably modulated by myriad growth factors, 
cytokines, and enzymes secreted from both resident cells and cells 
recruited from the circulation.9,10,21 the present data suggest that 
differences in arterial enlargement may contribute to carotid segment–
specific variation in the occurrence of occlusive lumen stenosis. Common 
carotid occlusion is rare, accounting for <1% of carotid disease cases.22 
The present data, as well as cross-sectional ARIC data,3 suggest that 
increased common carotid IMT is strongly associated with enlarged IA 
diameter and little or no decrease in lumen diameter. However, at the 
other extreme, our data suggest that increased internal carotid IMT is 
associated with decreased lumen diameter in the absence of IA diameter 
enlargement.  
 Fisher23,24 noted in the early 1950s that internal carotid stenosis and 
occlusion were more frequent than previously believed. Fisher et al25 later 
reported that among 178 autopsied cases, they found all cases of 
occlusive carotid disease (indeed, all significant stenoses) to occur distal 
to the common segment. In both the Cardiovascular Health Study (CHS) 
and the Framingham Study, researchers found that among asymptomatic 
participants >65Years old, 8% had significant carotid stenosis >50%.26,27 
Although the carotid arteries are the source of perhaps only 20% of all 
ischemic strokes,28 overall stroke incidence in asymptomatic patients with 
significant carotid lumen stenosis ranges from 2% to 8% per year, 
depending on the degree of lumen obstruction.22 Moreover, longitudinal 
follow-up within the ARIC and Cardiovascular Health Study populations 
suggests a graded increase in risk of incident ischemic stroke with 
increasing carotid IMT measured by B-mode ultrasound.29,30 The present 
data are consistent with the hypothesis that part of the risk of occlusive 
disease within the internal carotid is related to a relative lack of 
compensatory enlargement in that segment.and Remodeling accompanies 
significant progression of atherosclerosis in both the carotid4,5 and 
coronary6 arteries.  
CONCLUSIONS 
1.  Common carotid atherosclerosis is associated with larger IA 
diameter and no reduction in lumen diameter POSITIVE 
REMODELING. Conversely, in the internal carotid, greater IMT is 
associated with smaller lumina in the absence of IA diameter 
enlargement. NEGATIVE REMODELING 
 2.  Case-control comparisons suggest differences in arterial 
dimensions: common carotid IA diameter was greater in cases than 
controls, whereas internal carotid lumen and IA diameter were both 
reduced in CAD cases compared with controls. However, 
interactive effects of case status on the associations between IMT 
and arterial dimensions did not reach significance. Patients with 
triple vessel disease had significant remodeling of carotids when 
comparing patients with single vessel disease  
3.  The data is consistent with the concept that lack of arterial 
enlargement of the internal carotid during atherosclerosis 
progression partly explains the well-documented association of this 
carotid segment with symptomatic cardiovascular disease and the 
difference in the arterial biologic, physiologic and atherogenic 
prones properties of the different segments of carotid arteries  
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A STUDY ON CAROTID ARTERIAL REMODELING IN PATIENTS WITH 
OBSTRUCTIVE CORONARY ARTERY DISEASE AND DISEASE-FREE  
CONTROL SUBJECTS 
 
NAME  
AGE 
SEX 
OCCUPATION 
CD NUMBER 
SOCIOECONOMIC STATUS 
RISK FACTOR PROFILE 
HYPERTENSION 
DIABETES 
HYPERLIPEDIMIA 
SMOKING 
OBESITY 
PREVIOUS CAD 
FAMILY HISTORY OF CAD 
CLINICAL PROFILE 
VITAL PARAMETERS      PR                            BP 
 
 
TREADMILL TEST 
CORONARY ANGIOGRAM REPORT 
MEASUREMENTS 
 
COMMON CAROTID  
1. LUMINAL DIAMETER  
2. IMT   
3. INTRADVENTITIAL DIAMETER 
 
INTERNAL CAROTID  
1 .LUMINAL DIAMETER  
2. IMT   
3. INTRADVENTITIAL 
SERIAL 
NO. 
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CAROTID 
1.LUMINAL 
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3.INTRADVENTITIAL 
DIAMETER 
     
 INTERNAL 
CAROTID 
1.LUMINAL 
DIAMETER 
2. IMT
3.INTRADVENTITIAL 
DIAMETER 
     
 
 
 
CD num AGE SEX HEIGHT WEIGHT HTN DM SMOKING ECG ECHO TC TG HDL IC LD IC IMT IC IA CC LD CC IMT CC IAD TMT CAG
134536 43 M 162 54 N Y Y SR WNL NORMAL LV FUNCTION 234 156 48 5.94±0.04 0.85±0.02 7.53±0.11 6.77±0.16 0.93±0.04 8.28±0.14 NEGATIVE normal
178755 54 M 150 63 Y N Y SR WNL NORMAL LV FUNCTION 256 140 32 5.92±0.03 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
124545 34 F 148 46 Y Y N SR ,LVH NORMAL LV FUNCTION 276 148 34 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
152111 54 M 155 64 N Y Y SR,BAE,LVH,OLDawmi RWMA IN LV ANT WAL ,EF 53% 256 145 33 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
123474 54 F 164 75 N N N SR  ,prwp,T inv V1-v3 RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 246 134 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
123434 66 M 156 43 N N Y SR WNL NORMAL LV FUNCTION 264 121 42 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
134545 54 M 176 43 Y Y Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 274 111 55 6.06±0.11 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
134546 44 F 134 65 Y Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 356 110 45 6.20±0.12 0.88±0.04 7.87±0.21 6.22±0.29 1.27±0.08 8.12±0.26 NEGATIVE DVD
165625 76 F 147 53 N N N SR,OLD HLMI RWMA inANT,LAT WALL,EF42% 352 151 34 6.32±0.12 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.24±0.13 POSITIVE TVD
135534 54 M 163 54 Y N Y SR,OLD ASMI RWMA IN LV ANT WAL ,EF 53% 342 151 32 6.05±0.13 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143415 44 F 145 44 Y Y N SR ,LVH NORMAL LV FUNCTION 234 145 33 6.30±021 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.33±0.14 POSITIVE SVD
143457 34 M 162 43 N Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 321 134 35 6.05±0.07 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.33±0.26 POSITIVE DVD
176678 56 M 145 55 N N Y SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 233 127 42 6.16±0.07 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.965±0.13POSITIVE DVD
143143 67 M 164 66 Y Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 232 118 32 6.09±0.18 0.89±0.04 7.86±0.21 6.06±0.18 0.93±0.04 8.37±0.14 POSITIVE SVD
134347 65 F 155 66 Y Y N SR WNL RWMA IN LV ANT WALL,EF 45% 244 151 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.20±0.26 POSITIVE DVD
175453 66 F 148 54 N N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 231 157 33 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.84±0.13 POSITIVE TVD
165676 55 M 145 76 N Y Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 233 149 35 6.06±0.11 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
176767 45 F 176 86 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 245 136 42 6.20±0.12 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.38±0.14 POSITIVE SVD
176456 67 F 133 65 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 266 121 55 6.32±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
145634 54 F 136 56 N Y N SR WNL NORMAL LV FUNCTION 233 111 45 6.05±0.13 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.84±0.13 POSITIVE TVD
134545 54 F 137 54 Y N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 356 110 34 6.30±021 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.15±0.26 POSITIVE DVD
174563 54 M 156 54 Y N Y SR WNL RWMA IN LV ANT WALL,EF 45% 352 134 32 6.05±0.07 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
124543 66 F 176 64 N Y N SR WNL NORMAL LV FUNCTION 342 121 34 6.16±0.07 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.26±0.14 POSITIVE SVD
167543 54 M 134 64 N Y Y SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 234 111 33 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.12±0.26 POSITIVE DVD
145678 44 M 147 45 N N Y SR WNL RWMA IN LV ANT WALL,EF 45% 321 117 35 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.96±0.13 POSITIVE TVD
124565 76 M 163 65 Y N Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 233 171 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134535 54 F 145 67 Y Y N SR WNL NORMAL LV FUNCTION 232 151 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156743 65 M 162 65 N Y Y SR WNL NORMAL LV FUNCTION 244 145 45 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.27±0.14 POSITIVE SVD
123432 66 M 145 43 Y N Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 231 134 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.92±0.04 NEGATIVE normal
175433 55 F 164 43 Y Y N SR ,LVH NORMAL LV FUNCTION 276 171 55 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.27±0.14 POSITIVE SVD
187654 45 M 155 65 N Y Y SR WNL RWMA IN INFERO POST SEGMENT.EF 48% 256 127 45 5.88±0.09 0.85±0.02 7.56±0.11 6.86±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176543 67 F 148 53 N N N SR ,LVH NORMAL LV FUNCTION 246 118 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143546 54 M 145 54 Y Y Y SR WNL NORMAL LV FUNCTION 246 151 32 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
176542 54 M 176 44 Y N Y SR WNL RWMA IN LV ANT WALL,EF 45% 264 157 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.91±0.04 NEGATIVE normal
143567 54 F 133 43 N Y N SR WNL NORMAL LV FUNCTION 274 149 35 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
156563 54 F 136 55 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 356 136 42 5.88±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156743 66 M 137 66 Y N Y SR ,LVH NORMAL LV FUNCTION 352 121 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.91±0.04 NEGATIVE normal
134532 54 M 150 66 Y N N SR WNL NORMAL LV FUNCTION 342 111 55 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
156754 44 F 148 54 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 234 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176543 76 F 155 76 Y Y N SR WNL NORMAL LV FUNCTION 321 110 34 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
134344 54 F 164 86 Y N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 233 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.91±0.04 NEGATIVE normal
134543 44 M 156 65 N N Y SR ,LVH NORMAL LV FUNCTION 232 151 33 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
134353 34 F 176 54 N Y N SR WNL RWMA IN INFERO POST SEGMENT.EF 50% 244 121 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134354 56 M 134 54 N Y N SR ,LVH NORMAL LV FUNCTION 231 111 42 6.06±0.11 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
154453 67 M 147 64 Y N N SR ,OLD ASMI NORMAL LV FUNCTION 233 110 32 6.20±0.12 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
143444 65 M 163 64 Y Y Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 245 134 55 6.32±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143455 66 F 145 45 N Y N SR WNL NORMAL LV FUNCTION 266 121 45 6.05±0.13 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143413 55 F 147 65 Y N N SR ,LVH NORMAL LV FUNCTION 233 111 34 6.30±021 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
134576 45 M 163 67 Y Y N SR Tinv in 2,3,avf RWMA IN INFERO POST SEGMENT.EF 50% 356 110 32 6.05±0.07 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.91±0.04 NEGATIVE normal
165366 66 M 145 65 N N Y SR WNL NORMAL LV FUNCTION 352 151 33 6.16±0.07 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
165675 54 F 162 43 N Y N SR Tinv in 2,3,avf NORMAL LV FUNCTION 233 151 35 6.32±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
135546 44 M 145 43 Y Y Y SR WNL NORMAL LV FUNCTION 232 145 42 6.05±0.13 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
155355 76 F 164 65 Y N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 244 134 32 6.30±021 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
154554 54 M 155 53 N N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 231 121 55 6.05±0.07 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
135554 65 F 148 54 N Y Y SR,OLD HLMI RWMA inANT,LAT WALL,EF42% 276 110 45 6.16±0.07 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
156656 66 F 145 44 Y Y N SR,OLD ASMI RWMA IN LV ANT WAL ,EF 53% 256 151 34 6.06±0.11 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
135544 55 F 176 54 Y N N SR ,LVH NORMAL LV FUNCTION 246 151 32 6.20±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
146443 45 M 133 54 N N N SR WNL RWMA IN LV ANT WALL,EF 45% 246 145 33 6.32±0.12 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
145673 67 M 136 64 Y Y Y SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 264 110 32 6.05±0.13 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
187797 54 F 137 64 Y Y N SR WNL RWMA IN LV ANT WALL,EF 45% 274 134 55 6.30±021 1.31±0.09 7.54±0.17 6.21±0.11 1.01±0.14 8.84±0.12 NEGATIVE TVD
186585 54 M 176 45 N N N SR WNL RWMA IN LV ANT WALL,EF 45% 276 121 45 6.05±0.07 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
145788 54 M 134 65 N Y Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 256 111 34 6.16±0.07 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
198675 55 F 147 67 N Y Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 246 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156756 45 M 163 65 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 264 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134536 67 F 145 43 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 274 151 35 6.06±0.11 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
178755 54 M 162 43 N N N SR WNL NORMAL LV FUNCTION 356 145 42 6.20±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
124545 54 M 145 65 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 352 134 32 6.32±0.12 0.88±0.04 7.87±0.21 6.21±0.11 1.01±0.14 8.84±0.12 POSITIVE SVD
152111 54 F 164 53 Y Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 342 121 55 6.05±0.13 0.88±0.04 7.87±0.21 6.20±0.12 1.03±0.04 8.94±0.15 POSITIVE SVD
152111 54 F 155 54 N N N SR WNL NORMAL LV FUNCTION 234 110 45 6.30±021 0.84±0.02 7.53±0.11 6.25±0.12 1.05±0.04 8.94±0.13 NEGATIVE normal
123434 66 M 148 44 N N N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 321 151 34 6.05±0.07 0.84±0.02 7.53±0.11 6.26±0.12 1.03±0.04 8.96±0.13 NEGATIVE normal
134545 54 F 145 43 Y Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 233 110 32 6.16±0.07 0.84±0.02 7.53±0.11 6.28±0.12 1.05±0.04 8.94±0.13 NEGATIVE normal
134546 44 M 176 65 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 232 151 33 6.08±0.18 0.88±0.04 7.87±0.21 6.26±0.12 1.09±0.04 8.95±0.13 POSITIVE SVD
165625 76 M 133 53 N N N SR WNL NORMAL LV FUNCTION 233 151 35 6.08±0.18 0.88±0.04 7.87±0.21 6.25±0.12 1.05±0.04 8.96±0.13 NEGATIVE SVD
135534 54 M 136 54 N N N SR WNL NORMAL LV FUNCTION 232 145 42 5.98±0.09 0.84±0.02 7.53±0.11 6.25±0.12 1.06±0.04 8.94±0.13 NEGATIVE normal
143415 44 F 137 44 Y Y Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 244 134 32 5.98±0.09 0.84±0.02 7.53±0.11 6.24±0.12 1.05±0.04 8.96±0.13 NEGATIVE normal
143457 34 F 150 54 Y Y N SR ,LVH NORMAL LV FUNCTION 231 121 55 6.06±0.11 0.84±0.02 7.53±0.11 6.23±0.12 1.03±0.04 8.94±0.13 NEGATIVE normal
176678 55 M 148 54 N N N SR WNL RWMA IN INFERO POST SEGMENT.EF 48% 233 110 45 6.20±0.12 0.88±0.04 7.87±0.21 6.22±0.12 1.05±0.04 8.97±0.13 POSITIVE SVD
143143 45 F 155 64 Y Y N SR ,LVH NORMAL LV FUNCTION 245 151 34 6.32±0.12 0.84±0.02 7.53±0.11 6.25±0.12 1.03±0.04 8.95±0.13 NEGATIVE normal
134347 66 F 164 64 Y Y N SR WNL NORMAL LV FUNCTION 266 111 45 6.05±0.13 0.88±0.04 7.87±0.21 6.29±0.12 1.05±0.04 8.99±0.13 NEGATIVE SVD
175453 54 F 163 45 N N N SR WNL RWMA IN LV ANT WALL,EF 45% 233 110 34 6.30±021 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
165676 44 F 145 65 N Y N SR WNL NORMAL LV FUNCTION 356 134 32 6.05±0.07 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176767 76 M 162 67 N N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 352 121 34 6.16±0.07 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE SVD
176456 54 F 145 65 Y Y N SR ,LVH NORMAL LV FUNCTION 342 111 33 6.08±0.18 0.88±0.04 7.87±0.21 6.25±0.12 1.03±0.04 8.95±0.13 POSITIVE TVD
145634 65 M 164 43 Y Y N SR WNL NORMAL LV FUNCTION 234 110 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134545 66 M 155 65 N N Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 321 151 42 6.06±0.11 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
174563 55 M 148 53 Y N Y SR WNL NORMAL LV FUNCTION 233 151 55 6.20±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
124543 45 F 145 54 Y Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 232 145 45 6.32±0.12 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
167543 54 M 176 44 N Y N SR ,LVH NORMAL LV FUNCTION 244 134 34 6.05±0.13 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
145678 54 M 133 54 N N N SR WNL RWMA IN INFERO POST SEGMENT.EF 50% 231 121 55 6.30±021 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
124565 54 F 136 54 Y N N SR ,LVH NORMAL LV FUNCTION 276 110 45 6.05±0.07 0.84±0.02 7.53±0.11 6.26±0.12 1.09±0.04 8.95±0.13 POSITIVE normal
134535 55 M 137 64 Y Y N SR ,OLD ASMI NORMAL LV FUNCTION 256 151 34 6.16±0.07 0.84±0.02 7.53±0.11 6.25±0.12 1.05±0.04 8.96±0.13 NEGATIVE normal
156743 45 F 176 64 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 246 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.25±0.12 1.06±0.04 8.94±0.13 NEGATIVE normal
123432 67 M 134 45 N N Y SR WNL NORMAL LV FUNCTION 246 145 33 5.98±0.09 0.84±0.02 7.53±0.11 6.24±0.12 1.05±0.04 8.96±0.13 NEGATIVE normal
175433 54 M 147 65 Y Y Y SR ,LVH NORMAL LV FUNCTION 264 134 35 6.08±0.18 0.88±0.04 7.87±0.21 6.23±0.12 1.03±0.04 8.94±0.13 NEGATIVE SVD
187654 54 F 163 67 Y Y N SR Tinv in 2,3,avf RWMA IN INFERO POST SEGMENT.EF 50% 274 121 42 5.49±0.20 1.31±0.09 7.54±0.17 6.22±0.12 1.05±0.04 8.97±0.13 POSITIVE TVD
176543 54 F 145 65 N N N SR WNL NORMAL LV FUNCTION 356 134 32 6.06±0.11 0.88±0.04 7.87±0.21 6.25±0.12 1.03±0.04 8.95±0.13 NEGATIVE SVD
143546 54 M 162 43 Y Y N SR Tinv in 2,3,avf NORMAL LV FUNCTION 352 121 55 6.20±0.12 0.88±0.04 7.87±0.21 6.29±0.12 1.05±0.04 8.99±0.13 NEGATIVE SVD
176542 45 M 145 65 Y N Y SR WNL NORMAL LV FUNCTION 342 111 45 6.32±0.12 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143567 66 F 164 53 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 234 110 34 6.05±0.13 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156563 54 F 164 54 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 321 151 32 6.30±021 0.84±0.02 7.53±0.11 6.08±0.18 0.91±0.04 8.28±0.14 POSITIVE normal
156743 44 F 155 44 N N N SR,OLD HLMI RWMA inANT,LAT WALL,EF42% 233 151 33 6.05±0.07 0.84±0.02 7.53±0.11 6.25±0.12 1.03±0.04 8.95±0.13 NEGATIVE normal
134532 76 M 148 43 Y N Y SR,OLD ASMI RWMA IN LV ANT WAL ,EF 53% 232 121 35 6.16±0.07 0.88±0.04 7.87±0.21 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE SVD
156754 54 F 145 65 Y Y N SR ,LVH NORMAL LV FUNCTION 244 111 42 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
176543 65 M 176 53 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 231 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134344 66 M 133 54 Y N Y SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 233 134 55 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
134543 55 M 136 44 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 245 121 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.91±0.04 NEGATIVE normal
134353 45 F 137 44 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 266 111 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134354 44 F 150 54 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 233 110 32 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
154453 76 M 148 54 Y N Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 356 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143444 54 M 155 64 Y Y N SR WNL RWMA IN LV ANT WALL,EF 45% 352 151 35 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
143455 44 F 164 64 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 233 145 42 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
143413 34 M 156 45 N N Y SR WNL NORMAL LV FUNCTION 232 134 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 8.28±0.14 0.91±0.04 NEGATIVE normal
134576 56 F 176 65 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 244 121 55 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
165366 67 M 134 67 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 231 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
165675 65 F 147 65 N Y N SR WNL NORMAL LV FUNCTION 276 151 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
135546 66 F 163 43 Y Y N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 256 121 45 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
155355 55 F 145 43 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 246 111 34 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
154554 45 M 147 65 N N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 246 110 32 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
135554 67 M 163 53 N Y Y SR WNL NORMAL LV FUNCTION 264 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156656 54 F 145 54 N Y N SR WNL NORMAL LV FUNCTION 274 151 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
135544 54 F 162 64 Y N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 276 145 42 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
146443 54 F 145 64 Y N N SR ,LVH NORMAL LV FUNCTION 256 134 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
145673 66 M 164 45 N Y N SR WNL RWMA IN INFERO POST SEGMENT.EF 48% 246 121 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
187797 54 F 155 65 Y Y N SR ,LVH NORMAL LV FUNCTION 233 110 45 6.08±0.18 0.88±0.04 7.87±0.21 6.08±0.18 0.91±0.04 8.28±0.14 NEGATIVE SVD
186585 44 M 148 67 Y N Y SR WNL NORMAL LV FUNCTION 232 151 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
145788 76 M 145 65 N Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 244 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
198675 54 M 176 43 N Y N SR WNL NORMAL LV FUNCTION 231 145 33 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
156756 65 F 133 65 Y N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 233 110 32 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
134536 66 F 136 53 Y Y N SR ,LVH NORMAL LV FUNCTION 245 134 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
178755 55 M 137 54 N N N SR WNL NORMAL LV FUNCTION 266 121 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
124545 45 M 176 44 N Y Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 233 111 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
152111 67 F 134 43 Y Y N SR WNL NORMAL LV FUNCTION 356 110 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143143 54 M 147 65 Y N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 352 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
123434 54 F 163 45 N N N SR ,LVH NORMAL LV FUNCTION 342 151 35 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
134545 54 M 145 65 Y Y N SR WNL RWMA IN INFERO POST SEGMENT.EF 50% 234 145 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134546 54 F 162 67 Y Y N SR ,LVH NORMAL LV FUNCTION 321 134 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
165625 66 F 145 65 N N N SR ,OLD ASMI NORMAL LV FUNCTION 233 121 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
135534 54 F 164 43 N N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 232 110 45 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
143415 44 M 145 43 N Y Y SR WNL NORMAL LV FUNCTION 244 151 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
143457 76 M 164 65 Y Y N SR ,LVH NORMAL LV FUNCTION 231 121 45 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
176678 54 F 155 53 Y N N SR Tinv in 2,3,avf RWMA IN INFERO POST SEGMENT.EF 50% 276 111 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143143 44 M 148 54 N Y N SR WNL NORMAL LV FUNCTION 256 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134347 34 M 145 44 Y Y N SR Tinv in 2,3,avf NORMAL LV FUNCTION 246 151 33 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
175453 56 F 176 54 Y N N SR WNL NORMAL LV FUNCTION 246 151 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
165676 67 M 133 54 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 264 145 42 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
176767 65 F 136 64 N N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 274 134 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176456 66 M 137 64 Y Y N SR,OLD HLMI RWMA inANT,LAT WALL,EF42% 356 121 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
145634 55 M 150 45 Y Y Y SR,OLD ASMI RWMA IN LV ANT WAL ,EF 53% 352 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134545 45 F 148 65 N N N SR ,LVH NORMAL LV FUNCTION 342 151 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
174563 66 F 155 67 N N N SR WNL RWMA IN LV ANT WALL,EF 45% 234 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
124543 54 M 164 65 Y Y N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 321 151 33 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
167543 44 F 163 43 Y Y N SR WNL RWMA IN LV ANT WALL,EF 45% 233 151 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
145678 76 M 145 65 N N Y SR WNL RWMA IN LV ANT WALL,EF 45% 232 145 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
124565 54 M 162 53 Y N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 244 134 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
134535 65 M 145 54 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 231 121 55 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
156743 66 F 164 44 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 233 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
123432 55 F 155 43 N N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 245 151 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
175433 45 M 148 65 N Y N SR WNL NORMAL LV FUNCTION 266 111 45 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
187654 67 F 145 45 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 233 110 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
176543 54 F 176 65 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 356 134 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143546 54 F 133 67 N Y N SR WNL NORMAL LV FUNCTION 352 121 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176542 54 F 136 65 Y N N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 233 111 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143567 55 M 137 43 Y Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 232 110 35 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
156563 45 F 176 67 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 244 151 42 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
156743 67 M 134 65 N N N SR WNL NORMAL LV FUNCTION 231 151 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134532 54 M 147 43 Y N N SR WNL NORMAL LV FUNCTION 276 145 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
156754 54 M 163 65 Y Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 256 134 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
176543 54 F 145 53 N Y N SR ,LVH NORMAL LV FUNCTION 246 121 55 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
134344 54 M 162 54 N N Y SR WNL RWMA IN INFERO POST SEGMENT.EF 48% 246 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134543 66 M 145 44 Y N Y SR ,LVH NORMAL LV FUNCTION 264 151 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134353 54 F 164 43 Y Y N SR WNL NORMAL LV FUNCTION 274 151 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
134354 44 M 164 65 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 276 145 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
154453 76 F 155 45 Y N N SR WNL NORMAL LV FUNCTION 256 134 35 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143444 54 M 148 65 Y Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 246 121 42 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
143455 44 M 145 67 N Y N SR ,LVH NORMAL LV FUNCTION 232 134 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
143413 34 F 176 65 N N N SR WNL NORMAL LV FUNCTION 244 121 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134576 67 F 133 43 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 231 111 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
165366 54 M 162 45 Y N N SR WNL NORMAL LV FUNCTION 276 110 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
165675 54 M 145 65 Y Y Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 256 151 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
135546 54 F 164 67 N Y N SR ,LVH NORMAL LV FUNCTION 246 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
155355 55 F 155 65 Y N N SR WNL RWMA IN INFERO POST SEGMENT.EF 50% 246 121 35 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
154554 45 F 148 43 Y N N SR ,LVH NORMAL LV FUNCTION 264 111 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
135554 67 M 145 65 N Y N SR ,OLD ASMI NORMAL LV FUNCTION 274 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156656 54 F 176 53 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 276 134 55 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
135544 54 M 133 54 Y N N SR WNL NORMAL LV FUNCTION 256 121 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
146443 54 M 136 44 Y N N SR ,LVH NORMAL LV FUNCTION 246 111 34 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
145673 54 M 137 43 N Y N SR Tinv in 2,3,avf RWMA IN INFERO POST SEGMENT.EF 50% 233 110 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
187797 66 F 176 65 N Y N SR WNL NORMAL LV FUNCTION 232 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE DVD
186585 54 F 134 45 Y N Y SR Tinv in 2,3,avf NORMAL LV FUNCTION 244 151 35 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE normal
145788 44 M 147 65 Y Y N SR WNL NORMAL LV FUNCTION 231 145 42 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
198675 76 M 163 67 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 233 134 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156756 54 F 145 43 Y N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 245 121 55 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134536 44 M 162 65 Y Y N SR,OLD HLMI RWMA inANT,LAT WALL,EF42% 266 110 45 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
178755 34 F 145 53 N N N SR,OLD ASMI RWMA IN LV ANT WAL ,EF 53% 233 151 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
124545 44 M 164 54 N Y Y SR ,LVH NORMAL LV FUNCTION 232 121 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
152111 34 F 164 44 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 244 111 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
134546 67 F 155 44 Y N N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 231 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
123434 54 F 148 54 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 276 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134545 54 M 145 54 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 256 151 35 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
134546 54 M 176 64 Y Y Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 246 145 42 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
165625 55 F 133 64 Y N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 246 134 32 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 POSITIVE TVD
135534 45 M 136 45 N N Y SR WNL RWMA IN LV ANT WALL,EF 45% 264 121 55 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
143415 67 M 137 65 N Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 274 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
143457 54 F 150 67 Y Y N SR WNL NORMAL LV FUNCTION 276 151 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
176678 54 M 148 65 Y N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 256 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143143 54 F 155 44 N Y Y SR WNL RWMA IN LV ANT WALL,EF 45% 246 145 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134347 54 M 164 54 N Y N SR WNL NORMAL LV FUNCTION 233 110 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
175453 66 M 156 54 Y N N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 232 134 55 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
165676 44 F 176 64 Y Y N SR WNL RWMA IN LV ANT WALL,EF 45% 244 121 45 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
176767 34 F 134 64 N N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 231 111 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176456 67 M 147 45 Y Y Y SR WNL NORMAL LV FUNCTION 233 110 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
145634 54 F 163 65 Y Y N SR WNL NORMAL LV FUNCTION 245 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
134545 54 M 145 67 N N N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 266 151 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
174563 54 M 147 65 N N N SR ,LVH NORMAL LV FUNCTION 233 145 42 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
124543 55 M 163 43 N Y N SR WNL RWMA IN INFERO POST SEGMENT.EF 48% 232 134 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
167543 45 F 145 65 Y Y N SR ,LVH NORMAL LV FUNCTION 244 121 55 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
145678 67 F 162 53 Y N N SR WNL NORMAL LV FUNCTION 231 110 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
124565 54 M 145 54 N N N SR WNL RWMA IN LV ANT WALL,EF 45% 276 151 34 5.49±0.20 1.31±0.09 7.54±0.17 6.20±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
134535 54 F 164 44 Y Y N SR WNL NORMAL LV FUNCTION 256 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
156743 54 F 155 54 Y Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 246 145 33 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
123432 54 F 148 54 N N N SR ,LVH NORMAL LV FUNCTION 246 134 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
175433 66 F 137 53 N Y N SR WNL NORMAL LV FUNCTION 264 121 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
187654 44 M 176 54 Y Y Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 274 134 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
176543 34 F 134 44 Y N N SR WNL NORMAL LV FUNCTION 356 121 55 5.49±0.20 1.31±0.09 7.54±0.17 6.26±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
143546 67 M 147 44 N Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 352 111 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176542 54 M 163 54 N N N SR ,LVH NORMAL LV FUNCTION 342 110 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143567 54 M 145 54 Y Y N SR WNL RWMA IN INFERO POST SEGMENT.EF 50% 234 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
156563 54 F 162 64 Y Y N SR ,LVH NORMAL LV FUNCTION 321 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 POSITIVE normal
156743 55 M 145 64 N N Y SR ,OLD ASMI NORMAL LV FUNCTION 233 121 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134532 45 M 164 45 Y N Y SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 232 111 42 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
156754 67 F 164 65 Y Y N SR WNL NORMAL LV FUNCTION 244 110 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
176543 54 M 155 67 N Y N SR ,LVH NORMAL LV FUNCTION 231 134 55 5.49±0.20 1.31±0.09 7.54±0.17 6.26±0.12 1.09±0.04 8.95±0.13 POSITIVE TVD
134344 54 F 148 65 N N N SR Tinv in 2,3,avf RWMA IN INFERO POST SEGMENT.EF 50% 233 121 45 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134543 54 M 145 53 N N N SR WNL NORMAL LV FUNCTION 245 111 34 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
134353 54 M 176 54 Y Y N SR Tinv in 2,3,avf NORMAL LV FUNCTION 266 110 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 POSITIVE DVD
134354 66 F 133 44 Y Y N SR WNL NORMAL LV FUNCTION 232 151 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
154453 44 F 162 44 N N N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 244 151 35 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143444 76 M 136 54 Y Y N SR OLIWMI RWMA IN INFERO POST SEGMENT.EF 48% 231 145 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
143455 54 M 137 54 Y Y N SR,OLD HLMI RWMA inANT,LAT WALL,EF42% 276 134 32 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
143413 44 F 150 64 N N N SR,OLD ASMI RWMA IN LV ANT WAL ,EF 53% 256 121 55 5.49±0.20 1.31±0.09 7.54±0.17 6.24±0.12 1.05±0.04 8.96±0.13 POSITIVE TVD
134576 34 F 148 64 N Y N SR ,LVH NORMAL LV FUNCTION 246 145 33 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
165366 44 F 155 45 Y N N SR WNL RWMA IN LV ANT WALL,EF 45% 246 134 35 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
165675 34 M 164 65 Y Y N SR ,OLD ASMI RWMA IN LV ANT WALL,EF 45% 264 121 42 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
135546 67 F 163 67 N Y N SR WNL RWMA IN LV ANT WALL,EF 45% 274 111 55 5.49±0.20 1.31±0.09 7.54±0.17 6.25±0.12 1.03±0.04 8.94±0.13 NEGATIVE TVD
155355 54 M 145 65 N N N SR WNL RWMA IN LV ANT WALL,EF 45% 356 110 45 6.08±0.18 0.88±0.04 7.87±0.21 6.29±0.12 1.05±0.04 8.99±0.13 POSITIVE DVD
154554 54 M 162 65 Y N Y SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 352 151 34 6.08±0.18 0.88±0.04 7.87±0.21 6.22±0.29 1.07±0.08 8.10±0.26 NEGATIVE DVD
135554 54 M 145 43 Y Y N SR ,OLD ASMI RWMA IN DISTAL IVS ,LV APEX,ANTLAT WALL EF 38% 342 151 32 5.98±0.09 0.84±0.02 7.53±0.11 6.87±0.16 0.91±0.04 8.28±0.14 NEGATIVE normal
